WO2023277367A1 - Cosmetic composition comprising antarctic microorganism culture medium - Google Patents

Cosmetic composition comprising antarctic microorganism culture medium Download PDF

Info

Publication number
WO2023277367A1
WO2023277367A1 PCT/KR2022/007832 KR2022007832W WO2023277367A1 WO 2023277367 A1 WO2023277367 A1 WO 2023277367A1 KR 2022007832 W KR2022007832 W KR 2022007832W WO 2023277367 A1 WO2023277367 A1 WO 2023277367A1
Authority
WO
WIPO (PCT)
Prior art keywords
strain
skin
pseudoalteromonas
cosmetic composition
culture
Prior art date
Application number
PCT/KR2022/007832
Other languages
French (fr)
Korean (ko)
Inventor
김수영
김지웅
강승혜
김준호
김영수
Original Assignee
주식회사 라비오
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 라비오 filed Critical 주식회사 라비오
Publication of WO2023277367A1 publication Critical patent/WO2023277367A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions
    • A61K2800/5922At least two compounds being classified in the same subclass of A61K8/18

Definitions

  • the present invention relates to a cosmetic containing an Antarctic-derived microorganism or a culture solution thereof.
  • the skin is the most basic defense organ that protects the body against stimuli in contact with the external environment, and is an important organ that expresses external beauty.
  • melanin serves to protect the skin from ultraviolet rays, but when produced excessively, pigment is deposited on the skin to form spots and freckles, and in severe cases, it may cause skin cancer.
  • Melanin is a high-molecular natural pigment of phenols widely present in animals, plants, and microorganisms, and is synthesized in melanosomes in melanocytes present in the basal layer of the epidermis.
  • L-tyrosine is converted into L-DOPA (3,4-dihydrozyphenylalanine) by tyrosinase, and L-DOPA is phenyl It is oxidized to anin-3,4-quinone, and finally becomes melanin through intermediate metabolites.
  • L-DOPA 3,4-dihydrozyphenylalanine
  • keratinocytes in normal skin express structural proteins important for maintaining the skin barrier function, such as keratin or filaggrin, through a differentiation process to protect the skin from water loss and various environmental aggressions.
  • Moisturizing and skin barriers can change due to changes in the external environment and lifestyle due to sudden changes in temperature, irritation from environmental pollution, various stresses, excessive washing of the face, and natural aging due to age increase.
  • Natural materials not only have few side effects on the skin, but also the value of development as a raw material for cosmetics is gradually increasing as consumers' response to cosmetics using natural materials has recently increased.
  • the present invention is to solve the problems of the prior art described above, and an object of the present invention is to provide an eco-friendly cosmetic raw material with excellent skin improvement activity as well as biosafety.
  • the pseudojima antarctica Pseudozyma antarctica
  • Pseudo Alteromonas New Stonica Pseudoalteromonas neustonica
  • a cosmetic composition containing as an active ingredient is provided.
  • the Pseudozyma antarctica strain is Pseudozyma antarctica LAB-10 (accession number: KCTC 14550BP).
  • Pseudo Alteromonas New Stonica Pseudoalteromonas neustonica
  • the strain may be Pseudoalteromonas New Stonica LAB-08 (accession number: KCTC 14549BP).
  • the culture solution is Pseudozyma antarctica ( Pseudozyma antarctica ) strain or Pseudo Alteromonas New Stonica ( Pseudoalteromonas neustonica )
  • the culture medium itself obtained by culturing the strain, or the culture supernatant obtained by removing the strain therefrom , or a concentrate or lyophilizate of the culture supernatant.
  • the cosmetic composition may be for skin moisturizing or skin barrier strengthening.
  • the cosmetic composition may be used for skin whitening or improving skin tone.
  • the cosmetic composition softening lotion, nutrient lotion, moisture cream, nutrient cream, massage cream, nutrient lotion, essence, ampoule, gel, eye cream, oil, foundation, cleansing cream, cleansing foam, cleansing water, mask It may consist of one formulation selected from the group consisting of packs, sprays and powders.
  • Pseudojima antarctica Pseudozyma antarctica
  • Pseudoalteromonas New Tonica Pseudoalteromonas neustonica
  • a composition for external application for skin containing as an active ingredient.
  • the Antarctic-derived microorganisms produce a large amount of ingredients beneficial to the skin during the fermentation process, effectively inhibit melanin production and have an excellent skin moisturizing effect.
  • Figures 2 and 3 are the results of evaluating the expression level of AQP3 and HAS3 according to the strain culture and extract treatment according to an embodiment of the present invention.
  • Figure 4 is a result of measuring the skin tone improvement effect according to the strain culture medium and extract treatment according to an embodiment of the present invention.
  • Pseudojima Antarctica Pseudozyma antarctica
  • Pseudo Alteromonas New Stonica Pseudoalteromonas neustonica ) strain, its fermentation broth, lysate, extract or culture
  • the present inventors confirmed the excellent skin improvement effect of the culture solution and extract of the Pseudojima antarctica strain and the Pseudoalteromonas newstonica strain, and through this, it was found that it can be used as a cosmetic raw material for skin whitening and skin moisturizing.
  • the " Pseudozyma antarctica” is a microorganism isolated and identified in Antarctica that can produce an emulsified material, and produces a large amount of viscous polysaccharide (EPS) having whitening activity during cultivation and fermentation, resulting in skin whitening and skin tone. It can be used for improvement purposes.
  • EPS viscous polysaccharide
  • the “ Pseudoalteromonas neustonica ” strain is a microorganism isolated and identified from the surface microlayer of the Antarctic Ross Sea, and contains a large amount of GG (GlycerylGlucoside) having skin moisturizing activity during cultivation and fermentation. It can be produced and used for skin moisturizing and skin barrier strengthening.
  • GG GlycerylGlucoside
  • the present inventors confirmed that the fermentation broth, extract, and culture broth of the strain can exhibit better functionality through mutual synergistic activity when acting simultaneously.
  • the Pseudozyma antarctica strain may be Pseudozyma antarctica LAB-10 (accession number: KCTC 14550BP), and the Pseudoalteromonas Newstonica strain may be Pseudoalteromonas newstonica LAB-10. 08 (accession number: KCTC 14549BP).
  • the present inventors confirmed that they were Pseudojima antarctica strains and Pseudoalteromonas newtonica strains derived from Antarctica, and compared to conventional Antarctic microorganisms, they showed better skin quality. It was confirmed that it can exhibit improvement activity.
  • the culture solution is Pseudozyma antarctica strain or Pseudo Alteromonas New Stonica strain ( Pseudoalteromonas neustonica )
  • the culture medium itself obtained by culturing the strain, or the culture supernatant obtained by removing the strain therefrom, or the culture supernatant It may be a concentrate or lyophilizate.
  • the culture broth is a Pseudojima anthotica strain or Pseudoalteromonas newtonica strain at least one selected from the group consisting of glucose, fructose, mannose, galactose, xylose, ribose, maltose, sucrose, dextrin, glycerin, and inulin carbon source; And it may be obtained by culturing the strain in a medium containing at least one nitrogen source selected from the group consisting of potassium nitrate, ammonium nitrate, ammonium sulfate, ammonium oxalate, and inulin diammonium phosphate.
  • the carbon source or nitrogen source used in the culture medium is, for example, about 0.1 to 30 w/v%, 1 to 25 w/v%, 1 to 20 w/v%, 1 to 10 w/v%, 1 to 5 w/v %, or 1 to 1.5 w/v%.
  • the culture medium may include a salt commonly used in the culture medium of the strain, and the salt includes, for example, at least one salt selected from the group consisting of potassium nitrate, potassium sulfate, magnesium carbonate, magnesium sulfate, and magnesium nitrate.
  • the salt may be included in, for example, about 0.01 to 10 w/v%, 0.1 to 7 w/v%, or 0.5 to 5 w/v%.
  • the culture medium may include about 0.01 to 10 w/v%, 0.05 to 5 w/v%, or 0.1 to 2 w/v% of yeast autolysate, and the culture medium may have a pH of about 2.0 to 7.0. but not limited thereto.
  • the culture solution is the Pseudojima anthotica strain or Pseudoalteromonas newstonica strain, for example, about 20 to 42 °C, about 25 to 35 °C, or about 27 to 30 °C under temperature conditions, such as about 24 to 144 hours, 48 to 120 hours, or may be obtained by culturing for 15 to 35 hours.
  • the culture conditions of the strain may include adding the strain in a medium and fermenting it, and the fermenting step may use a commonly used fermentation method, for example, the method may use fed batch fermentation.
  • the extract may be obtained by extracting the separated culture solution of the Pseudojima antarctica strain or Pseudoalteromonas newstonica strain with various organic solvents.
  • the lysate is separated from the culture solution of the Pseudojima antarctica strain or Pseudoalteromonas newstonica strain, and then breaks the cell wall or cell membrane through mechanical methods or nonmechanical methods It may be obtained by releasing intracellular products.
  • the fermented broth may be obtained by culturing the Pseudojima antarica strain or the Pseudoalteromonas newstonica strain and extracting a fat-soluble component from a liquid medium in which the fermentation process is completed or therefrom.
  • the cosmetic composition may include, for example, 1 to 99.99% by weight, for example, 1.5 to 99.99% by weight, or 2 to 99.99% by weight of the Pseudojima antarctica strain and the Pseudoalteromonas newstonica strain, based on the total weight of the composition.
  • the Pseudojima antarctica strain and Pseudoalteromonas newtonica strain, their fermentation broth, lysate, extract or culture medium significantly reduce the amount of melanin production and at the same time exhibit skin moisturizing activity 2 with respect to the total weight of the cosmetic composition % (w/w) or more may be included.
  • the cosmetic composition may be used for moisturizing the skin or strengthening the skin barrier.
  • the “moisturizing the skin” refers to all actions to maintain the homeostasis of the skin tissue by properly controlling the loss of moisture (moisture evaporation) of the skin.
  • the skin moisturizing effect may be accompanied by additional skin improving effects in various aspects, such as an exfoliating effect and a skin irritation reducing effect.
  • the skin structure of the "skin barrier” is divided into the externally exposed epidermis and the inner dermis, which corresponds to the outermost stratum corneum in the epidermis.
  • the role of the skin barrier is to protect external harmful elements from invading the skin while protecting internal moisture from escaping.
  • stressening the skin barrier means that when the skin barrier is weakened, it becomes vulnerable to external stimuli and easily loses moisture, which increases the possibility that the skin becomes dry and sensitive.
  • the cosmetic composition may be used for skin whitening or skin tone improvement.
  • the "skin whitening" relieves skin pigmentation phenomena such as blemishes, freckles, and melasma by suppressing the production of various biomolecules such as melanin, oxidation-reduction hemoglobin, carotene, and melanoids that affect skin color, skin yellowing, It means the effect of improving skin brightness and uniformity by reducing redness.
  • the above “improvement of skin tone” means brightening the color of the skin and softening the skin texture. Since the skin tone is affected by melanin pigment, the skin tone improving effect may be accompanied by a skin whitening effect.
  • the cosmetic composition softening lotion, nutrient lotion, moisture cream, nutrient cream, massage cream, nutrient lotion, essence, ampoule, gel, eye cream, oil, foundation, cleansing cream, cleansing foam, cleansing water, mask pack, spray and powder It may consist of one formulation selected from the group consisting of, but is not limited thereto.
  • Pseudojima antarctica Pseudozyma antarctica
  • Pseudoalteromonas New Tonica Pseudoalteromonas neustonica
  • a composition for external application for skin containing as an active ingredient.
  • composition for external application for skin may be formulated with one or more selected from the group consisting of creams, gels, patches, sprays, ointments, warning agents, lotions, liniment agents, pasta agents, and cataplasma agents, but is not limited thereto.
  • the cosmetic composition may be formulated by conventional methods.
  • the International cosmetic ingredient dictionary, 6th ed (The Cosmetic, Toiletry and Fragrance Association, Inc., Washington, 1995) can be referred to, and the formulation of the skin external application Reference may be made to content disclosed in Remington's Pharmaceutical Science, Mack Publishing Company, Easton PA.
  • the cosmetic composition may be prepared in a general emulsified formulation and solubilized formulation.
  • cosmetic lotion such as softening lotion or nourishing lotion
  • emulsions such as facial lotion and body lotion
  • creams such as nourishing creams, moisture creams, and eye creams; essence; cosmetic ointment; spray; gel; pack; sunscreen; makeup base; foundations such as liquid type, solid type or spray type; powder
  • makeup removers such as cleansing creams, cleansing lotions, and cleansing oils
  • it may be formulated as a cleanser such as a cleansing foam, soap, body wash, etc., but is not limited thereto.
  • the cosmetic composition and the composition for external application for skin may be appropriately mixed with other components within a range that does not impair the purpose of the present invention depending on the type of formulation or purpose of use.
  • the cosmetic composition and composition for external application for skin may include a generally acceptable carrier, and for example, oil, water, surfactant, moisturizer, lower alcohol, thickener, chelating agent, colorant, preservative, fragrance, etc. may be appropriately blended. It is not limited to this.
  • the acceptable carrier may vary depending on the formulation.
  • animal oil, vegetable oil, wax, paraffin, starch, tracanthate, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc, zinc oxide or any of these as a carrier component when formulated into an ointment, paste, cream or gel Mixtures may be used.
  • compositions and composition for external application for skin are formulated as a powder or spray
  • lactose, talc, silica, aluminum hydroxide, calcium silicate, polyamide powder, or a mixture thereof may be used as a carrier component, and in the case of a spray It may further contain a propellant such as chlorofluorohydrocarbon, propane, butane or dimethyl ether.
  • a solvent, solubilizing agent, or emulsifying agent may be used as a carrier component, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl benzoate , propylene glycol, 1,3-butylglycol oil can be used, and in particular, cottonseed oil, peanut oil, corn germ oil, olive oil, castor oil and sesame oil, glycerol aliphatic esters, polyethylene glycol or fatty acid esters of sorbitan can be used.
  • a carrier component such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl benzoate , propylene glycol, 1,3-butylglycol oil
  • cottonseed oil, peanut oil, corn germ oil, olive oil, castor oil and sesame oil glycerol aliphatic esters, polyethylene glycol or fatty acid esters
  • the cosmetic composition and the composition for external application for skin are formulated as a suspension
  • water a liquid diluent such as ethanol or propylene glycol, ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester and Such suspending agents, microcrystalline cellulose, aluminum metahydroxide, bentonite, agar or tracanth, and the like can be used.
  • the cosmetic composition and the composition for external application for skin are formulated with soap, alkali metal salts of fatty acids, fatty acid hemiester salts, fatty acid protein hydrolyzates, isethionates, lanolin derivatives, fatty alcohols, vegetable oils, glycerol as carrier components , sugar, etc. may be used.
  • the cosmetic composition and composition for external application for skin may include fatty substances, organic solvents, solubilizers, thickeners, gelling agents, softeners, antioxidants, suspending agents, stabilizers, and foaming agents commonly used in the industry depending on the quality or function of the final product. agent), fragrance, surfactant, water, ionic or nonionic emulsifier, filler, sequestering agent, chelating agent, preservative, barrier agent, wetting agent, essential oil, dye, pigment, hydrophilic or lipophilic active agent, It may additionally contain adjuvants commonly used in the field of cosmetology or dermatology, such as any other commonly used ingredients.
  • the adjuvant and its mixing ratio may be appropriately selected so as not to affect desirable properties of the cosmetic composition according to the present invention.
  • Samples were taken from Jirisan ice bone, crushed, and homogenized. Then, 1.0 g of the sample was suspended in 9.0 mL of sterilized physiological saline (0.9% NaCl), diluted in stages, and smeared on YM growth medium, respectively.
  • strains having different colony types were selected and purified through several pure culture processes.
  • the pure isolated strain was spread on YM solid medium and cultured at 25 ° C for 24 hours, and the pure isolated colony was cultured on YM liquid medium and mixed with 20% (v / v) glycerol at a ratio of 1: 1 and stored in a -80 ° C cryogenic freezer.
  • ITS internal transcribed spacer
  • the isolated strain was identified as Pseudozyma antarctica.
  • the above identification bacteria was named Pseudojima Antarctica LAB-10, and it was deposited at the Biological Resource Center of the Jeonbuk Branch of the Korea Research Institute of Bioscience and Biotechnology on April 26, 2021, and was given the accession number KCTC 14550BP.
  • EPS exopolysaccharide
  • the appropriate culture conditions for exopolysaccharide (EPS) production of the identified microorganisms are 1 to 1.5 w/v% of dextrose, 0.2 to 0.4 w/v% of yeast extract, 0.2 to 0.4 w/v% of malt extract, and 0.4 to 0.7 w/v% of peptone in the medium.
  • v% containing 1 to 1.5 w/v% of each inorganic salt, after culturing at 25 ° C. at 200 rpm for 36 hours, and then culturing at 12 ° C. at 200 rpm for 12 hours, EPS derived from microorganisms under the above culture conditions The content was measured as 0.01% in the culture medium.
  • the strain was cultured with the medium composition, and the resulting culture medium was centrifuged at 5000 x g (10 minutes) to recover only the supernatant.
  • the strain was cultured with the medium composition, the resulting culture was extracted for 3 hours through ultrasonic extraction, and only the supernatant was recovered by centrifugation at 5000 x g (10 minutes).
  • Samples were collected from Jirisan ice bone, crushed, and homogenized. Then, 1.0 g of the sample was suspended in 9.0 mL of sterilized physiological saline (0.9% NaCl), diluted in stages, and smeared on a microbial growth medium (Difco Nutrient agar), respectively.
  • strains having different colony types were selected and purified through several pure culture processes.
  • the pure isolated strain was spread on a microbial solid medium and cultured at 25 ° C for 24 hours, and the pure isolated colony was cultured on NB liquid medium and mixed with 20% (v / v) glycerol at a ratio of 1: 1 and stored in a -80 ° C cryogenic freezer.
  • the strain was identified by searching NCBI blast.
  • the isolated strain was identified as Pseudoalteromonas neustonica.
  • the identification bacteria was named Pseudoalteromonas Newstonica LAB-08, and it was deposited at the Korea Research Institute of Bioscience and Biotechnology, Jeonbuk Branch Bioresource Center on April 26, 2021, and was given the accession number KCTC 14549BP.
  • the identified microorganism can produce intracellular glyceryl glucoside (GG) through fermentation, and an extract culture solution containing GG extracted from the microorganism was obtained by culturing the microorganism.
  • GG intracellular glyceryl glucoside
  • the appropriate culture conditions for producing glyceryl glucoside (GG) of the identified microorganisms are 0.5 to 1.5 w/v% of tryptone, 0.2 to 0.4 w/v% of yeast extract, 0.5 to 3 w/v% of NaCl, and 0.05 to 0.1 w/v% of KCl in the medium.
  • the strain was cultured with the medium composition, and the resulting culture medium was centrifuged at 5000 x g (10 minutes) to recover only the supernatant.
  • the strain was cultured with the medium composition, the resulting culture was extracted for 3 hours through ultrasonic extraction, and only the supernatant was recovered by centrifugation at 5000 x g (10 minutes).
  • a culture solution of 10% concentration was used, and the extract was 1 mg/mL concentration.
  • PAMC28425 culture medium (KCCM 43192) - - 10 - - 5 - - - - - 20 - - Pseudozyma antarctica ATCC34888 extract (KCCM 11472) - - - 10 - 5 - - - - - - 20 - Pseudoalteromonas sp.
  • PAMC28425 extract (KCCM 43192) - - - 10 - 5 - - - - - - - 20
  • Melamine content analysis (melanin contents assay) was evaluated for melanogenesis inhibition by the samples of Examples and Comparative Examples.
  • the B16F10 cell line was cultured in DMEM medium containing 10% fetal bovine serum (FBS) and 1X penicillin/streptomycin (P/S), and the cells were counted.
  • FBS fetal bovine serum
  • P/S penicillin/streptomycin
  • ⁇ -msh ( ⁇ -Melanocyte-stimulating hormone) was treated with 100 nM in a medium containing 10% FBS, and samples were diluted by concentration using the medium.
  • a positive control 200ppm arbutin was used, and the sample was cultured for 72 hours in a 5% CO 2 , 37°C incubator, and then the medium was removed and the cells were washed with DPBS.
  • the Pseudozyma antarctica LAB-10 or Pseudoalteromonas neustonica LAB-08 strain culture solution or extract (Comparative Examples 1 to 4) isolated by the present inventors is a conventional Antarctic microbial culture solution or extract (Comparative Examples 5 to 8 ) was evaluated as superior in melanin production inhibitory ability.
  • the skin moisturizing effect was evaluated using the samples of Examples and Comparative Examples.
  • the HaCaT cell line was cultured in DMEM medium containing 10% FBS (fetal bovine serum) and 1X penicillin/streptomycin (P/S), and after counting the cells, the number was 5 x 10 5 cells/well in a 6-well plate. Diluted and seeded, 5% CO 2 , and cultured for 24 hours in an incubator at 37°C.
  • FBS fetal bovine serum
  • P/S penicillin/streptomycin
  • 10M retinol was incubated with the sample in a 5% CO 2 , 37°C incubator for 24 hours, and then the medium was removed and washed with DPBS.
  • Taqman primers AQP3, HAS3, and GAPDH were purchased from life technologies and used. Using the Taqman master mix, the desired gene was amplified using Real-time PCR equipment Step One Plus Real-Time PCR (Applied Biosystem) to confirm changes in gene expression (Table 3).
  • the expression level of the gene was finally analyzed through correction for the GAPDH gene.
  • Pseudozyma antarctica Pseudozyma antarctica
  • Strains and Pseudo Alteromonas New Stonica Pseudoalteromonas neustonica
  • Examples 1 to 6 containing strain cultures or extracts at the same time are each single strain cultures or extracts compared to AQP3 and HAS3 expression was effectively promoted.
  • the Pseudozyma antarctica LAB-10 or Pseudoalteromonas neustonica LAB-08 strain culture solution or extract (Comparative Examples 1 to 4) isolated by the present inventors is a conventional Antarctic microbial culture solution or extract (Comparative Examples 5 to 8 ) was evaluated as excellent in skin moisturizing activity.
  • Example 5 The sample of Example 5 was formulated into a lotion type, and after applying to 20 subjects, the change in skin brightness was confirmed.
  • the measurement site was partitioned so that measurements could be made at the same site at each evaluation, and Example 5 and the control group were applied to the partitioned site, respectively.
  • Chromameter (CR-400, Konica-Minolta, Japan) was measured 5 times each, and then the average value of the measured values was recorded as the measured value.
  • the test site using the sample of Example 5 increased skin brightness (L-value) at a statistically significant level (p ⁇ 0.05) from 2 weeks after the test compared to before the test.
  • Example 5 can effectively improve skin tone by showing a statistically significant difference (p ⁇ 0.05) in comparison with the control area using the control group.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)

Abstract

The present invention relates to a cosmetic composition comprising, as active ingredients: a Pseudozyma antarctica strain, a fermentation solution thereof, a lysate thereof, an extract thereof or a culture medium thereof; and a Pseudoalteromonas neustonica strain, a fermentation solution thereof, a lysate thereof, an extract thereof or a culture medium thereof.

Description

남극 미생물 배양액을 포함하는 화장료 조성물Cosmetic Composition Containing Antarctic Microbial Culture
본 발명은 남극 유래 미생물 또는 이의 배양액을 함유하는 화장료에 관한 것이다.The present invention relates to a cosmetic containing an Antarctic-derived microorganism or a culture solution thereof.
피부는 외부환경과 접촉하여 자극에 대한 신체를 보호하는 가장 기초적인 방어기관이며, 외적인 아름다움을 표현하는 중요한 기관이다. The skin is the most basic defense organ that protects the body against stimuli in contact with the external environment, and is an important organ that expresses external beauty.
외적인 아름다움이 젊음과 건강을 상징하는 판단의 기준일 뿐 아니라 자신감을 표출하여 업무능력에 영향을 주는 경쟁력으로 자리잡고 있기 때문에, 현대사회에서 피부를 관리하는 경향이 증가하고 있다.Since external beauty is not only a criterion for judgment that symbolizes youth and health, but also a competitive edge that affects work ability by expressing confidence, the tendency to manage skin in modern society is increasing.
그러나 나이가 들어감에 따라 신진대사를 조절하는 각종 호르몬의 분비가 감소하고, 면역세포의 기능과 세포들의 활성이 저하되어 생체에 필요한 면역 단백질 및 생체 구성 단백질들의 생합성이 감소하고, 외적으로는 오존층 파괴와 같은 환경오염으로 인한 자외선, 자유 라디칼 및 활성산소의 증가로 인하여 발생하는 물리적, 화학적 자극 및 스트레스로 인해 피부의 정상기능이 약화되고 노화가 촉진되며 혈색이 나빠지고 피부가 주름지게 된다.However, with age, the secretion of various hormones that regulate metabolism decreases, and the function of immune cells and the activity of cells decrease, resulting in a decrease in the biosynthesis of immune proteins and biocomponent proteins necessary for the body, and externally destroying the ozone layer. Due to physical and chemical stimuli and stress caused by an increase in ultraviolet rays, free radicals, and active oxygen caused by environmental pollution such as, the normal function of the skin is weakened, aging is accelerated, complexion deteriorates, and the skin wrinkles.
한편, 멜라닌은 자외선으로부터 피부를 보호하는 역할을 하지만 과도하게 생성될 경우 피부에 색소가 침착되어 기미와 주근깨를 형성하며, 심할 경우 피부암의 원인이 되기도 한다. On the other hand, melanin serves to protect the skin from ultraviolet rays, but when produced excessively, pigment is deposited on the skin to form spots and freckles, and in severe cases, it may cause skin cancer.
따라서, 피부의 색소 침착 현상을 방지하기 위해서는 멜라닌 생성과정의 일부분을 저해하여 멜라닌 생성을 감소시켜야 한다.Therefore, in order to prevent pigmentation of the skin, it is necessary to reduce melanin production by inhibiting a part of the melanin production process.
멜라닌은 동, 식물과 미생물계에 널리 존재하는 페놀류의 고분자 천연색소로 표피 기저층에 존재하는 멜라닌 세포(melanocyte) 내의 멜라닌소체(melanosome)에서 합성이 된다.Melanin is a high-molecular natural pigment of phenols widely present in animals, plants, and microorganisms, and is synthesized in melanosomes in melanocytes present in the basal layer of the epidermis.
멜라닌은 L-티로신(L-tyrosine)의 연속적인 산화반응으로 합성되는데, L-티로신은 티로시나아제(tyrosinase)에 의해 L-DOPA(3,4-dihydrozyphenylalanine)으로 전환되고, L-DOPA는 페닐아닌-3,4-퀴논으로 산화되며, 중간 대사산물을 거쳐 최종적으로 멜라닌이 된다. Melanin is synthesized by a continuous oxidation reaction of L-tyrosine. L-tyrosine is converted into L-DOPA (3,4-dihydrozyphenylalanine) by tyrosinase, and L-DOPA is phenyl It is oxidized to anin-3,4-quinone, and finally becomes melanin through intermediate metabolites.
따라서 피부 미백과 관련된 기능성 화장품의 소재를 개발하기 위해서는 그 물질이 티로시나아제의 활성을 저해하는지의 여부가 중요하다.Therefore, in order to develop a material for functional cosmetics related to skin whitening, it is important whether the material inhibits the activity of tyrosinase.
또한, 정상 피부에서 각질형성세포는 분화과정을 통해 각질(keratin) 또는 필라그린(filaggrin)과 같은 피부 장벽 기능을 유지하는데 중요한 구조 단백질을 발현시켜 수분 손실 및 여러 환경적 침해로부터 피부를 보호한다.In addition, keratinocytes in normal skin express structural proteins important for maintaining the skin barrier function, such as keratin or filaggrin, through a differentiation process to protect the skin from water loss and various environmental aggressions.
보습과 피부장벽은 외부환경의 변화와 생활패턴의 변화의 따라 온도의 급격한 변화, 환경오염으로 인한 자극, 각종 스트레스, 무리한 세안 및 연령증가에 의한 자연스러운 노화를 원인으로 달라질 수 있다. Moisturizing and skin barriers can change due to changes in the external environment and lifestyle due to sudden changes in temperature, irritation from environmental pollution, various stresses, excessive washing of the face, and natural aging due to age increase.
이러한 현상을 방지하고 톤이 밝은 피부를 유지하기 위해서, 기존에 알려진 각종 동물, 식물, 미생물 등으로부터 얻은 생리 활성 물질들을 화장품에 부가하여 산화로 인한 피부노화를 방지함으로써 피부를 개선시키고자 노력하고 있으며, 특히 화장품 업계는 여러 화학물질 등에 의한 피부 자극을 줄이기 위해 천연물을 사용한 다수의 제품을 개발하고 있다. In order to prevent this phenomenon and maintain a bright skin tone, we are trying to improve the skin by adding physiologically active substances obtained from various known animals, plants, microorganisms, etc. to cosmetics to prevent skin aging due to oxidation. , In particular, the cosmetics industry is developing a number of products using natural products to reduce skin irritation caused by various chemicals.
천연 재료는 피부에 부작용이 적을 뿐 아니라, 최근 천연 재료를 이용한 화장품에 대한 소비자들의 호응이 높아짐에 따라 화장품 원료로서 개발가치가 점차 증가하고 있다.Natural materials not only have few side effects on the skin, but also the value of development as a raw material for cosmetics is gradually increasing as consumers' response to cosmetics using natural materials has recently increased.
현 상황에서 미생물을 이용한 발효물 및 바이오 전환 기술이 화장품 소재 분야에서 적극적으로 활용되고 있으며, 이를 통해 멜라닌 생성을 효과적으로 억제할 뿐만 아니라 즉각적으로 피부 보습에 영향을 주는 미생물 기반 화장품 소재를 찾아내기 위한 노력이 요구되고 있다.In the current situation, fermented products and bio-conversion technology using microorganisms are actively used in the field of cosmetic materials, and through this, efforts to find microorganism-based cosmetic materials that not only effectively suppress melanin production but also immediately affect skin moisturizing this is being requested
본 발명은 전술한 종래 기술의 문제점을 해결하기 위한 것으로, 본 발명의 목적은 생체 안전성과 함께 피부 개선 활성이 우수한 친환경 화장료 원료를 제공하는 것이다.The present invention is to solve the problems of the prior art described above, and an object of the present invention is to provide an eco-friendly cosmetic raw material with excellent skin improvement activity as well as biosafety.
본 발명의 일 측면에 따르면, 상기 슈도지마 안타티카(Pseudozyma antarctica) 균주, 이의 발효액, 파쇄액, 추출액 또는 배양액; 및 슈도알테로모나스 뉴스토니카(Pseudoalteromonas neustonica) 균주, 이의 발효액, 파쇄액, 추출액 또는 배양액;을 유효성분으로 포함하는 화장료 조성물이 제공된다.According to one aspect of the present invention, the pseudojima antarctica ( Pseudozyma antarctica ) strain, its fermentation broth, lysate, extract or culture solution; And Pseudo Alteromonas New Stonica ( Pseudoalteromonas neustonica ) strain, its fermentation broth, lysate, extract or culture; a cosmetic composition containing as an active ingredient is provided.
일 실시예에 있어서, 상기 슈도지마 안타티카(Pseudozyma antarctica) 균주는 슈도지마 안타티카 LAB-10(수탁번호: KCTC 14550BP)일 수 있다.In one embodiment, the Pseudozyma antarctica strain is Pseudozyma antarctica LAB-10 (accession number: KCTC 14550BP).
일 실시예에 있어서, 슈도알테로모나스 뉴스토니카(Pseudoalteromonas neustonica) 균주는 슈도알테로모나스 뉴스토니카 LAB-08(수탁번호: KCTC 14549BP)일 수 있다.In one embodiment, Pseudo Alteromonas New Stonica ( Pseudoalteromonas neustonica ) The strain may be Pseudoalteromonas New Stonica LAB-08 (accession number: KCTC 14549BP).
일 실시예에 있어서, 상기 배양액은 슈도지마 안타티카(Pseudozyma antarctica) 균주 또는 슈도알테로모나스 뉴스토니카(Pseudoalteromonas neustonica) 균주를 배양하여 수득된 배양액 자체, 또는 이로부터 균주를 제거하여 수득된 배양 상층액, 또는 배양 상층액의 농축물 또는 동결건조물일 수 있다.In one embodiment, the culture solution is Pseudozyma antarctica ( Pseudozyma antarctica ) strain or Pseudo Alteromonas New Stonica ( Pseudoalteromonas neustonica ) The culture medium itself obtained by culturing the strain, or the culture supernatant obtained by removing the strain therefrom , or a concentrate or lyophilizate of the culture supernatant.
일 실시예에 있어서, 상기 화장료 조성물은 피부 보습 또는 피부장벽강화용일 수 있다.In one embodiment, the cosmetic composition may be for skin moisturizing or skin barrier strengthening.
일 실시예에 있어서, 상기 화장료 조성물은 피부 미백용 또는 피부톤 개선용일 수 있다.In one embodiment, the cosmetic composition may be used for skin whitening or improving skin tone.
일 실시예에 있어서, 상기 화장료 조성물 유연화장수, 영양화장수, 수분크림, 영양크림, 마사지크림, 영양로션, 에센스, 앰플, 젤, 아이크림, 오일, 파운데이션, 클렌징크림, 클렌징폼, 클렌징워터, 마스크팩, 스프레이 및 파우더로 이루어진 군에서 선택된 하나의 제형으로 이루어질 수 있다.In one embodiment, the cosmetic composition softening lotion, nutrient lotion, moisture cream, nutrient cream, massage cream, nutrient lotion, essence, ampoule, gel, eye cream, oil, foundation, cleansing cream, cleansing foam, cleansing water, mask It may consist of one formulation selected from the group consisting of packs, sprays and powders.
본 발명의 다른 측면에 따르면, 슈도지마 안타티카(Pseudozyma antarctica) 균주, 이의 발효액, 파쇄액, 추출액 또는 배양액; 및 슈도알테로모나스 뉴스토니카(Pseudoalteromonas neustonica) 균주, 이의 발효액, 파쇄액, 추출액 또는 배양액;을 유효성분으로 포함하는 피부외용제 조성물이 제공된다. According to another aspect of the present invention, Pseudojima antarctica ( Pseudozyma antarctica ) strain, its fermentation broth, lysate, extract or culture solution; And Pseudoalteromonas New Tonica ( Pseudoalteromonas neustonica ) strain, its fermentation broth, lysate, extract or culture; there is provided a composition for external application for skin containing as an active ingredient.
본 발명에 따르면, 상기 남극 유래의 미생물은 발효 과정에서 피부에 유익한 성분을 다량 생성하여, 멜라닌 생성을 효과적으로 억제하며 피부 보습 효과가 우수하다.According to the present invention, the Antarctic-derived microorganisms produce a large amount of ingredients beneficial to the skin during the fermentation process, effectively inhibit melanin production and have an excellent skin moisturizing effect.
본 발명의 효과는 상기한 효과로 한정되는 것은 아니며, 본 발명의 상세한 설명 또는 청구범위에 기재된 발명의 구성으로부터 추론 가능한 모든 효과를 포함하는 것으로 이해되어야 한다.The effects of the present invention are not limited to the above effects, and should be understood to include all effects that can be inferred from the detailed description of the present invention or the configuration of the invention described in the claims.
도 1은 본 발명의 일 실시예에 따른 균주 배양액 및 추출액의 멜라닌 생성 억제 효과를 평가한 결과이다.1 is a result of evaluating the melanin production inhibitory effect of the strain culture medium and extract according to an embodiment of the present invention.
도 2 및 3은 본 발명의 일 실시예에 따른 균주 배양액 및 추출액 처리에 따른 AQP3 및 HAS3 발현량을 평가한 결과이다.Figures 2 and 3 are the results of evaluating the expression level of AQP3 and HAS3 according to the strain culture and extract treatment according to an embodiment of the present invention.
도 4는 본 발명의 일 실시예에 따른 균주 배양액 및 추출액 처리에 따른 피부톤 개선 효과를 측정한 결과이다.Figure 4 is a result of measuring the skin tone improvement effect according to the strain culture medium and extract treatment according to an embodiment of the present invention.
본 명세서에서 사용되는 용어는 본 발명에서의 기능을 고려하면서 가능한 현재 널리 사용되는 일반적인 용어들을 선택하였으나, 이는 당 분야에 종사하는 기술자의 의도 또는 판례, 새로운 기술의 출현 등에 따라 달라질 수 있다. The terms used in this specification have been selected from general terms that are currently widely used as much as possible while considering the functions in the present invention, but these may vary depending on the intention of a person skilled in the art, precedent, or the emergence of new technologies.
또한, 특정한 경우는 출원인이 임의로 선정한 용어도 있으며, 이 경우 해당되는 발명의 설명 부분에서 상세히 그 의미를 기재할 것이다. 따라서 본 발명에서 사용되는 용어는 단순한 용어의 명칭이 아닌, 그 용어가 가지는 의미와 본 발명의 전반에 걸친 내용을 토대로 정의되어야 한다.In addition, in a specific case, there is also a term arbitrarily selected by the applicant, and in this case, the meaning will be described in detail in the description of the invention. Therefore, the term used in the present invention should be defined based on the meaning of the term and the overall content of the present invention, not simply the name of the term.
다르게 정의되지 않는 한, 기술적이거나 과학적인 용어를 포함해서 여기서 사용되는 모든 용어들은 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자에 의해 일반적으로 이해되는 것과 동일한 의미를 가지고 있다. 일반적으로 사용되는 사전에 정의되어 있는 것과 같은 용어들은 관련 기술의 문맥상 가지는 의미와 일치하는 의미를 가지는 것으로 해석되어야 하며, 본 출원에서 명백하게 정의하지 않는 한, 이상적이거나 과도하게 형식적인 의미로 해석되지 않는다. Unless defined otherwise, all terms used herein, including technical or scientific terms, have the same meaning as commonly understood by one of ordinary skill in the art to which the present invention belongs. Terms such as those defined in commonly used dictionaries should be interpreted as having a meaning consistent with the meaning in the context of the related art, and unless explicitly defined in this application, it should not be interpreted in an ideal or excessively formal meaning. don't
수치 범위는 상기 범위에 정의된 수치를 포함한다. 본 명세서에 걸쳐 주어진 모든 최대의 수치 제한은 낮은 수치 제한이 명확히 쓰여져 있는 것처럼 모든 더 낮은 수치 제한을 포함한다. 본 명세서에 걸쳐 주어진 모든 최소의 수치 제한은 더 높은 수치 제한이 명확히 쓰여져 있는 것처럼 모든 더 높은 수치 제한을 포함한다. 본 명세서에 걸쳐 주어진 모든 수치 제한은 더 좁은 수치 제한이 명확히 쓰여져 있는 것처럼, 더 넓은 수치 범위 내의 더 좋은 모든 수치 범위를 포함할 것이다.Numerical ranges are inclusive of the values defined therein. Every maximum numerical limitation given throughout this specification includes every lower numerical limitation, as if such lower numerical limitations were expressly written. Every minimum numerical limitation given throughout this specification includes every higher numerical limitation, as if such higher numerical limitations were expressly written. Every numerical limitation given throughout this specification will include every better numerical range within the broader numerical range, as if the narrower numerical limitations were expressly written.
이하, 본 발명의 실시예를 상세히 기술하나, 하기 실시예에 의해 본 발명이 한정되지 아니함은 자명하다.Hereinafter, embodiments of the present invention will be described in detail, but it is obvious that the present invention is not limited by the following examples.
본 발명의 일 측면은 슈도지마 안타티카(Pseudozyma antarctica) 균주, 이의 발효액, 파쇄액, 추출액 또는 배양액; 및 슈도알테로모나스 뉴스토니카(Pseudoalteromonas neustonica) 균주, 이의 발효액, 파쇄액, 추출액 또는 배양액;을 유효성분으로 포함하는 화장료 조성물을 제공한다.One aspect of the present invention is Pseudojima Antarctica ( Pseudozyma antarctica ) strain, its fermentation broth, lysate, extract or culture medium; And Pseudo Alteromonas New Stonica ( Pseudoalteromonas neustonica ) strain, its fermentation broth, lysate, extract or culture; provides a cosmetic composition containing as an active ingredient.
본 발명자들은 슈도지마 안타티카 균주 및 슈도알테로모나스 뉴스토니카 균주의 배양액 및 추출액의 우수한 피부 개선 효과를 확인하였으며, 이를 통해 피부 미백, 피부 보습을 위한 화장품 원료로서 사용할 수 있음을 규명하였다.The present inventors confirmed the excellent skin improvement effect of the culture solution and extract of the Pseudojima antarctica strain and the Pseudoalteromonas newstonica strain, and through this, it was found that it can be used as a cosmetic raw material for skin whitening and skin moisturizing.
상기 "슈도지마 안타티카(Pseudozyma antarctica)"는 남극에서 분리 및 동정된 미생물로 유화물질을 생성할 수 있으며, 배양 및 발효 과정에서 미백 활성을 가지는 점성 다당체(EPS)를 다량 생성하여, 피부 미백 및 피부톤 개선을 위한 용도로서 사용할 수 있다.The " Pseudozyma antarctica " is a microorganism isolated and identified in Antarctica that can produce an emulsified material, and produces a large amount of viscous polysaccharide (EPS) having whitening activity during cultivation and fermentation, resulting in skin whitening and skin tone. It can be used for improvement purposes.
상기 “슈도알테로모나스 뉴스토니카(Pseudoalteromonas neustonica)”균주는 남극 로스해(Ross Sea) 해수면 미세층에서 분리 및 동정된 미생물로, 배양 및 발효 과정에서 피부 보습 활성을 가지는 GG(GlycerylGlucoside)를 다량 생성하여, 피부 보습 및 피부장벽강화를 위한 용도로서 사용할 수 있다.The “ Pseudoalteromonas neustonica ” strain is a microorganism isolated and identified from the surface microlayer of the Antarctic Ross Sea, and contains a large amount of GG (GlycerylGlucoside) having skin moisturizing activity during cultivation and fermentation. It can be produced and used for skin moisturizing and skin barrier strengthening.
특히, 본 발명자들은 상기 균주의 발효액, 추출액, 배양액은 동시에 작용할 때 상호 시너지 활성을 통해 더욱 우수한 기능성을 나타낼 수 있음을 확인하였다.In particular, the present inventors confirmed that the fermentation broth, extract, and culture broth of the strain can exhibit better functionality through mutual synergistic activity when acting simultaneously.
상기 슈도지마 안타티카(Pseudozyma antarctica) 균주는 슈도지마 안타티카 LAB-10(수탁번호: KCTC 14550BP)일 수 있고, 상기 슈도알테로모나스 뉴스토니카(Pseudoalteromonas neustonica) 균주는 슈도알테로모나스 뉴스토니카 LAB-08(수탁번호: KCTC 14549BP)일 수 있다.The Pseudozyma antarctica strain may be Pseudozyma antarctica LAB-10 (accession number: KCTC 14550BP), and the Pseudoalteromonas Newstonica strain may be Pseudoalteromonas newstonica LAB-10. 08 (accession number: KCTC 14549BP).
본 발명자들은 국내의 한 지역(지리산 얼음골)에서 수득한 미생물을 동정한 결과 남극에서 유래한 슈도지마 안타티카 균주 및 슈도알테로모나스 뉴스토니카 균주임을 확인하였으며, 종래의 남극 미생물과 비교하여 더욱 우수한 피부 개선 활성을 나타낼 수 있음을 확인하였다.As a result of identifying the microorganisms obtained from a region in Korea (Mt. Jiri Eumeumgol), the present inventors confirmed that they were Pseudojima antarctica strains and Pseudoalteromonas newtonica strains derived from Antarctica, and compared to conventional Antarctic microorganisms, they showed better skin quality. It was confirmed that it can exhibit improvement activity.
상기 배양액은 슈도지마 안타티카(Pseudozyma antarctica) 균주 또는 슈도알테로모나스 뉴스토니카(Pseudoalteromonas neustonica) 균주를 배양하여 수득된 배양액 자체, 또는 이로부터 균주를 제거하여 수득된 배양 상층액, 또는 배양 상층액의 농축물 또는 동결건조물일 수 있다.The culture solution is Pseudozyma antarctica strain or Pseudo Alteromonas New Stonica strain ( Pseudoalteromonas neustonica ) The culture medium itself obtained by culturing the strain, or the culture supernatant obtained by removing the strain therefrom, or the culture supernatant It may be a concentrate or lyophilizate.
상기 배양액은 슈도지마 안타티카 균주 또는 슈도알테로모나스 뉴스토니카 균주를 글루코오스, 프룩토오스, 만노오스, 갈락토오스, 자일로스, 리보오스, 말토오스, 수크로오스, 덱스트린, 글리세린, 및 이눌린으로 이루어진 군으로부터 선택된 1종 이상의 탄소원; 및 질산칼륨, 질산암모늄, 황산암모늄, 옥살산암모늄, 및 인산이암모늄 이눌린으로 이루어진 군으로부터 선택된 1종 이상의 질소원을 포함하는 배지에 상기 균주를 배양시켜 수득한 것일 수 있다.The culture broth is a Pseudojima anthotica strain or Pseudoalteromonas newtonica strain at least one selected from the group consisting of glucose, fructose, mannose, galactose, xylose, ribose, maltose, sucrose, dextrin, glycerin, and inulin carbon source; And it may be obtained by culturing the strain in a medium containing at least one nitrogen source selected from the group consisting of potassium nitrate, ammonium nitrate, ammonium sulfate, ammonium oxalate, and inulin diammonium phosphate.
상기 배양 배지에서 사용되는 탄소원 또는 질소원은 예컨대, 약 0.1 내지 30 w/v%, 1 내지 25 w/v%, 1 내지 20 w/v%, 1 내지 10 w/v%, 1 내지 5w/v%, 또는 1 내지 1.5 w/v%로 포함될 수 있다. The carbon source or nitrogen source used in the culture medium is, for example, about 0.1 to 30 w/v%, 1 to 25 w/v%, 1 to 20 w/v%, 1 to 10 w/v%, 1 to 5 w/v %, or 1 to 1.5 w/v%.
상기 배양 배지는 균주의 배양 배지에서 통상적으로 사용되는 염을 포함할 수 있고, 상기 염은 예컨대 질산칼륨, 황산칼륨, 탄산마그네슘, 황산마그네슘, 및 질산마그네슘으로 이루어진 군으로부터 선택된 1종 이상의 염을 포함할 수 있으며, 상기 염은 예컨대, 약 0.01 내지 10 w/v%, 0.1 내지 7 w/v%, 또는 0.5 내지 5 w/v%로 포함될 수 있다.The culture medium may include a salt commonly used in the culture medium of the strain, and the salt includes, for example, at least one salt selected from the group consisting of potassium nitrate, potassium sulfate, magnesium carbonate, magnesium sulfate, and magnesium nitrate. The salt may be included in, for example, about 0.01 to 10 w/v%, 0.1 to 7 w/v%, or 0.5 to 5 w/v%.
상기 배양 배지는 약 0.01 내지 10w/v%, 0.05 내지 5 w/v%, 또는 0.1 내지 2w/v%의 효모 자가 용해물을 포함할 수 있으며, 상기 배양 배지는 약 2.0 내지 7.0의 pH일 수 있으나 이에 제한되지 않는다.The culture medium may include about 0.01 to 10 w/v%, 0.05 to 5 w/v%, or 0.1 to 2 w/v% of yeast autolysate, and the culture medium may have a pH of about 2.0 to 7.0. but not limited thereto.
상기 배양액은 상기 슈도지마 안타티카 균주 또는 슈도알테로모나스 뉴스토니카 균주를 예컨대, 약 20 내지 42℃, 약 25 내지 35 ℃, 또는 약 27 내지 30 ℃ 의 온도 조건 하에 예컨대 약 24내지 144시간, 48 내지 120시간, 또는 15 내지 35시간 동안 배양하여 수득된 것일 수 있다.The culture solution is the Pseudojima anthotica strain or Pseudoalteromonas newstonica strain, for example, about 20 to 42 ℃, about 25 to 35 ℃, or about 27 to 30 ℃ under temperature conditions, such as about 24 to 144 hours, 48 to 120 hours, or may be obtained by culturing for 15 to 35 hours.
상기 균주의 배양 조건은 배지에서 상기 균주를 첨가하여 발효시키는 단계를 포함할 수 있으며, 발효시키는 단계는 통상적으로 사용하는 발효 방법을 사용할 수 있으며, 예컨대 상기 방법은 유가식(fed batch) 발효를 사용할 수 있다.The culture conditions of the strain may include adding the strain in a medium and fermenting it, and the fermenting step may use a commonly used fermentation method, for example, the method may use fed batch fermentation. can
상기 추출액은 분리된 상기 슈도지마 안타티카 균주 또는 슈도알테로모나스 뉴스토니카 균주의 배양액을 여러 유기용매로 추출하여 수득한 것일 수 있다.The extract may be obtained by extracting the separated culture solution of the Pseudojima antarctica strain or Pseudoalteromonas newstonica strain with various organic solvents.
상기 파쇄액은 상기 슈도지마 안타티카 균주 또는 슈도알테로모나스 뉴스토니카 균주의 배양액으로부터 균주를 분리한 후 기계적인 방법(mechanical methods) 또는 비기계적인 방법(nonmechanical methods)을 통해 세포벽 또는 세포막을 파쇄시키고 세포 내 생성물(intracellular products)을 방출시켜 수득한 것일 수 있다.The lysate is separated from the culture solution of the Pseudojima antarctica strain or Pseudoalteromonas newstonica strain, and then breaks the cell wall or cell membrane through mechanical methods or nonmechanical methods It may be obtained by releasing intracellular products.
상기 발효액은 상기 슈도지마 안타티카 균주 또는 슈도알테로모나스 뉴스토니카 균주를 배양하고 발효 과정이 완료된 액체 배지 또는 이로부터 지용성 성분을 추출하여 수득한 것일 수 있다.The fermented broth may be obtained by culturing the Pseudojima antarica strain or the Pseudoalteromonas newstonica strain and extracting a fat-soluble component from a liquid medium in which the fermentation process is completed or therefrom.
상기 화장료 조성물은 상기 슈도지마 안타티카 균주 및 슈도알테로모나스 뉴스토니카 균주를 조성물 총 중량에 대하여 예컨대 1 내지 99.99 중량%, 예컨대, 1.5 내지 99.99 중량%, 2 내지 99.99 중량% 포함할 수 있다.The cosmetic composition may include, for example, 1 to 99.99% by weight, for example, 1.5 to 99.99% by weight, or 2 to 99.99% by weight of the Pseudojima antarctica strain and the Pseudoalteromonas newstonica strain, based on the total weight of the composition.
상기 슈도지마 안타티카 균주 및 슈도알테로모나스 뉴스토니카 균주, 이의 발효액, 파쇄액, 추출액 또는 배양액은 멜라닌 생성량을 유의하게 감소시키고, 동시에 피부 보습 활성을 나타낼 수 있다는 측면에서 화장료 조성물 총 중량에 대하여 2%(w/w) 이상 포함될 수 있다.The Pseudojima antarctica strain and Pseudoalteromonas newtonica strain, their fermentation broth, lysate, extract or culture medium significantly reduce the amount of melanin production and at the same time exhibit skin moisturizing activity 2 with respect to the total weight of the cosmetic composition % (w/w) or more may be included.
상기 화장료 조성물은 피부 보습 또는 피부 장벽 강화용일 수 있다.The cosmetic composition may be used for moisturizing the skin or strengthening the skin barrier.
상기 "피부 보습"은 피부의 수분 손실(수분 증발) 등을 적절히 조절하여 피부조직의 항상성을 유지하는 모든 행위를 의미한다. 상기 피부 보습 효과는 각질 개선효과, 피부자극 감소효과 등 다양한 측면의 추가적인 피부 개선 효과를 수반할 수 있다.The "moisturizing the skin" refers to all actions to maintain the homeostasis of the skin tissue by properly controlling the loss of moisture (moisture evaporation) of the skin. The skin moisturizing effect may be accompanied by additional skin improving effects in various aspects, such as an exfoliating effect and a skin irritation reducing effect.
상기 “피부장벽”이란 피부 구조는 외부에 드러나 있는 표피와 안쪽의 진피로 나뉘는데 표피에서도 가장 바깥쪽에 위치한 각질층에 해당하는 부분이다. 상기 피부장벽의 역할은 외부 유해 요소가 피부에 침입하지 못하도록 방어하면서, 내부 수분이 빠져나가지 않도록 보호하는 것이다.The skin structure of the "skin barrier" is divided into the externally exposed epidermis and the inner dermis, which corresponds to the outermost stratum corneum in the epidermis. The role of the skin barrier is to protect external harmful elements from invading the skin while protecting internal moisture from escaping.
상기 “피부장벽강화”란 피부 장벽이 약해지면 외부 자극에 취약해지고 수분을 쉽게 잃어 피부가 건조, 민감해질 가능성이 높아지는 바, 이를 예방, 방지 또는 개선하는 것을 말한다.The term "strengthening the skin barrier" means that when the skin barrier is weakened, it becomes vulnerable to external stimuli and easily loses moisture, which increases the possibility that the skin becomes dry and sensitive.
상기 화장료 조성물은 피부 미백용 또는 피부톤 개선용일 수 있다.The cosmetic composition may be used for skin whitening or skin tone improvement.
상기 "피부 미백"은 피부색에 영향을 미치는 멜라닌, 산화-환원 헤모글로빈, 카로틴, 멜라노이드 등 다양한 생체 분자의 생성을 억제함으로써 잡티, 주근깨, 기미 등의 피부 색소 침착 현상을 완화시키고, 피부 누런기, 붉은기를 완화시켜 피부 밝기 및 균일도를 향상시키는 효과를 의미한다.The "skin whitening" relieves skin pigmentation phenomena such as blemishes, freckles, and melasma by suppressing the production of various biomolecules such as melanin, oxidation-reduction hemoglobin, carotene, and melanoids that affect skin color, skin yellowing, It means the effect of improving skin brightness and uniformity by reducing redness.
상기기 “피부톤 개선”은 피부의 색을 밝게하고 피부 결을 부드럽게 해주는 것을 의미한다. 상기 피부톤은 멜라닌 색소에 영향을 받기 때문에 상기 피부톤 개선 효과는 피부 미백 효과가 동반될 수 있다. The above “improvement of skin tone” means brightening the color of the skin and softening the skin texture. Since the skin tone is affected by melanin pigment, the skin tone improving effect may be accompanied by a skin whitening effect.
상기 화장료 조성물 유연화장수, 영양화장수, 수분크림, 영양크림, 마사지크림, 영양로션, 에센스, 앰플, 젤, 아이크림, 오일, 파운데이션, 클렌징크림, 클렌징폼, 클렌징워터, 마스크팩, 스프레이 및 파우더로 이루어진 군에서 선택된 하나의 제형으로 이루어질 수 있으나 이에 제한되는 것은 아니다.The cosmetic composition softening lotion, nutrient lotion, moisture cream, nutrient cream, massage cream, nutrient lotion, essence, ampoule, gel, eye cream, oil, foundation, cleansing cream, cleansing foam, cleansing water, mask pack, spray and powder It may consist of one formulation selected from the group consisting of, but is not limited thereto.
본 발명의 다른 측면에 따르면, 슈도지마 안타티카(Pseudozyma antarctica) 균주, 이의 발효액, 파쇄액, 추출액 또는 배양액; 및 슈도알테로모나스 뉴스토니카(Pseudoalteromonas neustonica) 균주, 이의 발효액, 파쇄액, 추출액 또는 배양액;을 유효성분으로 포함하는 피부외용제 조성물이 제공된다. According to another aspect of the present invention, Pseudojima antarctica ( Pseudozyma antarctica ) strain, its fermentation broth, lysate, extract or culture solution; And Pseudoalteromonas New Tonica ( Pseudoalteromonas neustonica ) strain, its fermentation broth, lysate, extract or culture; there is provided a composition for external application for skin containing as an active ingredient.
상기 피부 외용제 조성물은 크림, 젤, 패치, 분무제, 연고제, 경고제, 로션제, 리니멘트제, 파스타제 및 카타플라스마제로 이루어진 군에서 선택된 하나 이상으로 제형화될 수 있으나, 이에 제한되는 것은 아니다.The composition for external application for skin may be formulated with one or more selected from the group consisting of creams, gels, patches, sprays, ointments, warning agents, lotions, liniment agents, pasta agents, and cataplasma agents, but is not limited thereto.
상기 화장료 조성물은 통상의 방법에 의해 제형화될 수 있다. 상기 화장료 조성물의 제형화에 있어서, 예컨대, International cosmetic ingredient dictionary, 6th ed(The cosmetic, Toiletry and Fragrance Association, Inc., Washington, 1995)에 개시되어 있는 내용을 참조할 수 있고, 상기 피부 외용제의 제형화에 있어서 Remington's Pharmaceutical Science, Mack Publishing Company, Easton PA에 개시되어 있는 내용을 참조할 수 있다.The cosmetic composition may be formulated by conventional methods. In the formulation of the cosmetic composition, for example, the International cosmetic ingredient dictionary, 6th ed (The Cosmetic, Toiletry and Fragrance Association, Inc., Washington, 1995) can be referred to, and the formulation of the skin external application Reference may be made to content disclosed in Remington's Pharmaceutical Science, Mack Publishing Company, Easton PA.
구체적으로, 상기 화장료 조성물은 일반적인 유화 제형 및 가용화 제형으로 제조할 수 있다. 예컨대, 유연 화장수 또는 영양 화장수 등의 화장수; 훼이셜 로션, 바디로션 등의 유액; 영양 크림, 수분 크림, 아이 크림 등의 크림; 에센스; 화장연고; 스프레이; 젤; 팩; 선 스크린; 메이크업 베이스; 액체 타입, 고체 타입 또는 스프레이 타입 등의 파운데이션; 파우더; 클렌징 크림, 클렌징 로션, 클렌징 오일 등의 메이크업 제거제; 또는 클렌징 폼, 비누, 바디워시 등의 세정제로 제형화될 수 있으나 이에 한정되는 것은 아니다. Specifically, the cosmetic composition may be prepared in a general emulsified formulation and solubilized formulation. For example, cosmetic lotion, such as softening lotion or nourishing lotion; emulsions such as facial lotion and body lotion; creams such as nourishing creams, moisture creams, and eye creams; essence; cosmetic ointment; spray; gel; pack; sunscreen; makeup base; foundations such as liquid type, solid type or spray type; powder; makeup removers such as cleansing creams, cleansing lotions, and cleansing oils; Alternatively, it may be formulated as a cleanser such as a cleansing foam, soap, body wash, etc., but is not limited thereto.
상기 화장료 조성물 및 피부 외용제 조성물은 각각의 제형에 있어서 상기 필수성분 외에 제형의 종류 또는 사용 목적 등에 따라 본 발명에 따른 목적을 저해하지 않는 범위 내에서 다른 성분들이 적절히 배합될 수 있다.In addition to the essential components in each formulation, the cosmetic composition and the composition for external application for skin may be appropriately mixed with other components within a range that does not impair the purpose of the present invention depending on the type of formulation or purpose of use.
상기 화장료 조성물 및 피부 외용제 조성물은 통상적으로 허용 가능한 담체를 포함할 수 있으며, 예컨대 유분, 물, 계면활성제, 보습제, 저급 알코올, 증점제, 킬레이트제, 색소, 방부제, 향료 등을 적절히 배합할 수 있으나, 이에 한정되는 것은 아니다.The cosmetic composition and composition for external application for skin may include a generally acceptable carrier, and for example, oil, water, surfactant, moisturizer, lower alcohol, thickener, chelating agent, colorant, preservative, fragrance, etc. may be appropriately blended. It is not limited to this.
상기 허용 가능한 담체는 제형에 따라 달리할 수 있다. 예컨대, 연고, 페이스트, 크림 또는 젤로 제형화될 때 담체 성분으로서 동물성 유, 식물성 유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크, 산화아연 또는 이들의 혼합물이 사용될 수 있다.The acceptable carrier may vary depending on the formulation. For example, animal oil, vegetable oil, wax, paraffin, starch, tracanthate, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc, zinc oxide or any of these as a carrier component when formulated into an ointment, paste, cream or gel Mixtures may be used.
상기 화장료 조성물 및 피부 외용제 조성물은 파우더 또는 스프레이로 제형화될 때, 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록사이드, 칼슘 실케이트, 폴리아미드 파우더 또는 이들의 혼합물이 사용될 수 있고, 스프레이의 경우 클로로플루오로히드로카본, 프로판, 부탄 또는 디메틸 에테르와 같은 추진제를 더 포함할 수 있다.When the cosmetic composition and composition for external application for skin are formulated as a powder or spray, lactose, talc, silica, aluminum hydroxide, calcium silicate, polyamide powder, or a mixture thereof may be used as a carrier component, and in the case of a spray It may further contain a propellant such as chlorofluorohydrocarbon, propane, butane or dimethyl ether.
상기 화장료 조성물 및 피부 외용제 조성물은 용액 또는 유탁액으로 제형화될 때, 담체 성분으로서 용매, 용해화제, 또는 유탁화제가 사용될 수 있고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 벤조에이트, 프로필렌 글리콜, 1,3-브틸글리콜 오일이 사용될 수 있고, 특히, 목화씨 오일, 땅콩 오일, 옥수수 배종 오일, 올리브 오일, 피마자 오일 및 참깨 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 사용될 수 있다. When the cosmetic composition and composition for external application for skin are formulated as a solution or emulsion, a solvent, solubilizing agent, or emulsifying agent may be used as a carrier component, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl benzoate , propylene glycol, 1,3-butylglycol oil can be used, and in particular, cottonseed oil, peanut oil, corn germ oil, olive oil, castor oil and sesame oil, glycerol aliphatic esters, polyethylene glycol or fatty acid esters of sorbitan can be used. can be used
상기 화장료 조성물 및 피부 외용제 조성물은 현탁액으로 제형화될 때, 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상의 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리 옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 사용될 수 있다.When the cosmetic composition and the composition for external application for skin are formulated as a suspension, water, a liquid diluent such as ethanol or propylene glycol, ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester and Such suspending agents, microcrystalline cellulose, aluminum metahydroxide, bentonite, agar or tracanth, and the like can be used.
상기 화장료 조성물 및 피부 외용제 조성물은 비누로 제형화될 때, 담체 성분으로서 지방산의 알칼리 금속 염, 지방산 헤미에스테르 염, 지방산 단백질 히드롤리제이트, 이세티오네이트, 라놀린 유도체, 지방족 알코올, 식물성 유, 글리세롤, 당 등이 사용될 수 있다.When the cosmetic composition and the composition for external application for skin are formulated with soap, alkali metal salts of fatty acids, fatty acid hemiester salts, fatty acid protein hydrolyzates, isethionates, lanolin derivatives, fatty alcohols, vegetable oils, glycerol as carrier components , sugar, etc. may be used.
상기 화장료 조성물 및 피부 외용제 조성물은 최종 제품의 품질이나 기능에 따라 업계에서 통상적으로 사용되는 지방 물질, 유기용매, 용해제, 농축제, 겔화제, 연화제, 항산화제, 현탁화제, 안정화제, 발포제(foaming agent), 방향제, 계면활성제, 물, 이온형 또는 비이온형 유화제, 충전제, 금속이온봉 쇄제, 킬레이트화제, 보존제, 차단제, 습윤화제, 필수 오일, 염료, 안료, 친수성 또는 친유성 활성제, 화장품에 통상적으로 사용되는 임의의 다른 성분과 같은 화장품학 또는 피부과학 분야에서 통상적으로 사용되는 보조제를 추가적으로 함유할 수 있다.The cosmetic composition and composition for external application for skin may include fatty substances, organic solvents, solubilizers, thickeners, gelling agents, softeners, antioxidants, suspending agents, stabilizers, and foaming agents commonly used in the industry depending on the quality or function of the final product. agent), fragrance, surfactant, water, ionic or nonionic emulsifier, filler, sequestering agent, chelating agent, preservative, barrier agent, wetting agent, essential oil, dye, pigment, hydrophilic or lipophilic active agent, It may additionally contain adjuvants commonly used in the field of cosmetology or dermatology, such as any other commonly used ingredients.
다만, 상기 보조제 및 그 혼합 비율은 본 발명에 따른 화장료 조성물의 바람직한 성질에 영향을 미치지 않도록 적절히 선택할 수 있다.However, the adjuvant and its mixing ratio may be appropriately selected so as not to affect desirable properties of the cosmetic composition according to the present invention.
이하 실시예를 통해, 본 발명을 더욱 상술하나 하기 실시예에 의해 본 발명이 제한되지 아니함은 자명하다.Through the following examples, the present invention is further detailed, but it is obvious that the present invention is not limited by the following examples.
제조예 1-1 : 미생물(Preparation Example 1-1: Microorganisms ( Pseudozyma antarcticaPseudozyma antarctica ) 분리 및 동정) isolation and identification
지리산 얼음골로부터 시료를 채취하여 파쇄하고 균질화시킨 후 이 중 1.0g을 취하여 멸균한 생리식염수(0.9% NaCl) 9.0mL에 현탁하고 단계적으로 희석하여 YM 증식배지에 각각 도말하였다. Samples were taken from Jirisan ice bone, crushed, and homogenized. Then, 1.0 g of the sample was suspended in 9.0 mL of sterilized physiological saline (0.9% NaCl), diluted in stages, and smeared on YM growth medium, respectively.
25 ℃에서 24 내지 48시간 배양한 다음 집락의 형태가 서로 다른 균주들을 선별하여 여러 번의 순수 배양(pure culture) 과정을 통하여 순수 분리하였다. After culturing at 25 ° C. for 24 to 48 hours, strains having different colony types were selected and purified through several pure culture processes.
순수 분리한 균주를 YM 고체배지에 도말하여 25℃에서 24시간 배양하였으며, 순수 분리된 집락을 YM 액체배지에 배양하여 20%(v/v) 글리세롤(glycerol)l과 1:1의 비율로 혼합하여 -80℃ 초저온 냉동고에 보관하였다.The pure isolated strain was spread on YM solid medium and cultured at 25 ° C for 24 hours, and the pure isolated colony was cultured on YM liquid medium and mixed with 20% (v / v) glycerol at a ratio of 1: 1 and stored in a -80 ° C cryogenic freezer.
균주를 동정하기 위해 Internal transcribed spacer(ITS) 염기서열과 26S rRNA의 염기서열을 분석한 후, NCBI blast를 검색하여 균주 동정을 하였다. In order to identify the strain, the internal transcribed spacer (ITS) nucleotide sequence and 26S rRNA nucleotide sequence were analyzed, and the strain was identified by searching NCBI blast.
염기서열 분석결과, 분리된 균주는 슈도지마 안타티카(Pseudozyma antarctica)인 것으로 동정되었다. As a result of sequencing, the isolated strain was identified as Pseudozyma antarctica.
상기 동정균을 슈도지마 안타티카 LAB-10 로 명명하였고, 이를 한국생명공학연구원 전북분원 생물자원센터에 2021년 4월 26일자로 기탁하고, 기탁번호 KCTC 14550BP 를 부여받았다.The above identification bacteria was named Pseudojima Antarctica LAB-10, and it was deposited at the Biological Resource Center of the Jeonbuk Branch of the Korea Research Institute of Bioscience and Biotechnology on April 26, 2021, and was given the accession number KCTC 14550BP.
제조예 1-2 : 미생물(Preparation Example 1-2: Microorganisms ( Pseudozyma antarcticaPseudozyma antarctica ) 배양액 및 추출액 제조) Preparation of culture medium and extract
상기 동정 미생물은 발효를 통해 exopolysaccharide(EPS)를 생성하여 세포 외로 분비하므로, 상기 미생물을 배양하고 이로부터 배양액을 수득하였다. Since the identified microorganism produces exopolysaccharide (EPS) through fermentation and secretes it extracellularly, the microorganism was cultured and a culture solution was obtained therefrom.
상기 동정 미생물의 exopolysaccharide(EPS) 생성 적정배양조건은 배지 내 dextrose 1 내지 1.5 w/v%, yeast extract 0.2 내지 0.4 w/v%, malt extract 0.2 내지 0.4 w/v%, peptone 0.4 내지 0.7 w/v%, 각각의 무기염류 1 내지 1.5 w/v% 로 포함하고, 25℃에서 200rpm으로 36시간 배양 후, 12℃에서 200rpm으로 12시간 배양하였을 때로 확인되었으며, 상기 배양조건에서 미생물로부터 유래되는 EPS 함량은 배양액 내 0.01%로 측정되었다.The appropriate culture conditions for exopolysaccharide (EPS) production of the identified microorganisms are 1 to 1.5 w/v% of dextrose, 0.2 to 0.4 w/v% of yeast extract, 0.2 to 0.4 w/v% of malt extract, and 0.4 to 0.7 w/v% of peptone in the medium. v%, containing 1 to 1.5 w/v% of each inorganic salt, after culturing at 25 ° C. at 200 rpm for 36 hours, and then culturing at 12 ° C. at 200 rpm for 12 hours, EPS derived from microorganisms under the above culture conditions The content was measured as 0.01% in the culture medium.
배양액의 효능을 분석하기 위해 상기 배지 조성물로 균주를 배양시켜, 생산한 배양액을 5000 x g(10분) 원심 분리하여 상등액만 회수하였다. In order to analyze the efficacy of the culture medium, the strain was cultured with the medium composition, and the resulting culture medium was centrifuged at 5000 x g (10 minutes) to recover only the supernatant.
상등액을 0.2 ㎛ 필터를 사용하여 제균 여과 후, 최종 배양액을 수득하였다. After filtering the supernatant using a 0.2 μm filter for sterilization, the final culture solution was obtained.
추출액의 효능을 분석하기 위해 상기 배지 조성물로 균주를 배양시켜, 생산한 배양액을 초음파추출을 통해 3시간 동안 추출을 진행하고, 5000 x g(10분) 원심 분리하여 상등액만 회수하였다.In order to analyze the efficacy of the extract, the strain was cultured with the medium composition, the resulting culture was extracted for 3 hours through ultrasonic extraction, and only the supernatant was recovered by centrifugation at 5000 x g (10 minutes).
상등액을 0.2 ㎛ 필터를 사용하여 제균 여과 후, 최종 추출액을 수득하였다.After filtering the supernatant using a 0.2 μm filter for sterilization, the final extract was obtained.
제조예 2-1 : 미생물(Preparation Example 2-1: Microorganisms ( Pseudoalteromonas neustonicaPseudoalteromonas neustonica )의 분리 및 동정) Isolation and identification of
지리산 얼음골로부터 시료를 채취하여 파쇄하고 균질화시킨 후 이 중 1.0g을 취하여 멸균한 생리식염수(0.9% NaCl) 9.0mL에 현탁하고 단계적으로 희석하여 미생물 증식배지(Difco Nutrient agar)에 각각 도말하였다.Samples were collected from Jirisan ice bone, crushed, and homogenized. Then, 1.0 g of the sample was suspended in 9.0 mL of sterilized physiological saline (0.9% NaCl), diluted in stages, and smeared on a microbial growth medium (Difco Nutrient agar), respectively.
25℃에서 24 내지 48시간 배양한 다음 집락의 형태가 서로 다른 균주들을 선별하여 여러 번의 순수 배양(pure culture) 과정을 통하여 순수 분리하였다.After culturing at 25° C. for 24 to 48 hours, strains having different colony types were selected and purified through several pure culture processes.
순수 분리한 균주를 미생물 고체배지에 도말하여 25℃에서 24시간 배양하였으며, 순수 분리된 집락을 NB 액체배지에 배양하여 20%(v/v) 글리세롤(glycerol)l과 1:1의 비율로 혼합하여 -80℃ 초저온 냉동고에 보관하였다.The pure isolated strain was spread on a microbial solid medium and cultured at 25 ° C for 24 hours, and the pure isolated colony was cultured on NB liquid medium and mixed with 20% (v / v) glycerol at a ratio of 1: 1 and stored in a -80 ° C cryogenic freezer.
균주를 동정하기 위해 16S rRNA의 염기서열을 분석한 후, NCBI blast를 검색하여 균주 동정을 하였다.After analyzing the base sequence of 16S rRNA to identify the strain, the strain was identified by searching NCBI blast.
염기서열 분석결과, 분리된 균주는 슈도알테로모나스 뉴스토니카(Pseudoalteromonas neustonica)인 것으로 동정되었다. As a result of sequencing, the isolated strain was identified as Pseudoalteromonas neustonica.
상기 동정균을 슈도알테로모나스 뉴스토니카 LAB-08 로 명명하였고, 이를 한국생명공학연구원 전북분원 생물자원센터에 2021년 4월 26일자로 기탁하고, 기탁번호 KCTC 14549BP 를 부여받았다.The identification bacteria was named Pseudoalteromonas Newstonica LAB-08, and it was deposited at the Korea Research Institute of Bioscience and Biotechnology, Jeonbuk Branch Bioresource Center on April 26, 2021, and was given the accession number KCTC 14549BP.
제조예 2-2 : 미생물(Preparation Example 2-2: Microorganisms ( Pseudoalteromonas neustonicaPseudoalteromonas neustonica ) 배양액 및 추출액 제조) Preparation of culture medium and extract
상기 동정 미생물은 발효를 통해 세포 내 glyceryl glucoside(GG)를 생성할 수 있으며, 상기 미생물을 배양하고 이로부터 추출된 GG를 포함하는 추출 배양액을 수득하였다. The identified microorganism can produce intracellular glyceryl glucoside (GG) through fermentation, and an extract culture solution containing GG extracted from the microorganism was obtained by culturing the microorganism.
상기 동정 미생물의 glyceryl glucoside(GG) 생성 적정배양조건은 배지 내 tryptone 0.5 내지 1.5 w/v%, yeast extract 0.2 내지 0.4 w/v%, NaCl 0.5 내지 3 w/v%, KCl 0.05 내지 0.1 w/v%, CaCl2 0.1 내지 0.2 w/v%, MgCl2·6H2O 0.3 내지 0.7 w/v%, NaHCO3 0.01 내지 0.02 w/v%, MgSO4·7H2O 0.2 내지 0.4 w/v% 로 포함하며, 25℃에서 200rpm으로 36시간 배양 후, 12℃에서 200rpm으로 12시간 배양하였을 때로 확인되었으며, 상기 배양조건에서 미생물로부터 유래되는 GG 함량은 배양액 내 1.6%로 측정되었다.The appropriate culture conditions for producing glyceryl glucoside (GG) of the identified microorganisms are 0.5 to 1.5 w/v% of tryptone, 0.2 to 0.4 w/v% of yeast extract, 0.5 to 3 w/v% of NaCl, and 0.05 to 0.1 w/v% of KCl in the medium. v%, CaCl 2 0.1 to 0.2 w/v%, MgCl 2 6H 2 O 0.3 to 0.7 w/v%, NaHCO3 0.01 to 0.02 w/v%, MgSO 4 7H 2 O 0.2 to 0.4 w/v% Including, it was confirmed when cultured at 200 rpm at 25 ° C. for 36 hours and then cultured at 12 ° C. at 200 rpm for 12 hours.
배양액의 효능을 분석하기 위해 상기 배지 조성물로 균주를 배양시켜, 생산한 배양액을 5000 x g(10분) 원심 분리하여 상등액만 회수하였다. In order to analyze the efficacy of the culture medium, the strain was cultured with the medium composition, and the resulting culture medium was centrifuged at 5000 x g (10 minutes) to recover only the supernatant.
상등액을 0.2 ㎛ 필터를 사용하여 제균 여과 후, 최종 배양액을 수득하였다. After filtering the supernatant using a 0.2 μm filter for sterilization, the final culture solution was obtained.
추출액의 효능을 분석하기 위해 상기 배지 조성물로 균주를 배양시켜, 생산한 배양액을 초음파추출을 통해 3시간 동안 추출을 진행하고, 5000 x g(10분) 원심 분리하여 상등액만 회수하였다.In order to analyze the efficacy of the extract, the strain was cultured with the medium composition, the resulting culture was extracted for 3 hours through ultrasonic extraction, and only the supernatant was recovered by centrifugation at 5000 x g (10 minutes).
상등액을 0.2 ㎛ 필터를 사용하여 제균 여과 후, 최종 추출액을 수득하였다.After filtering the supernatant using a 0.2 μm filter for sterilization, the final extract was obtained.
실시예 및 비교예Examples and Comparative Examples
본원발명의 균주 배양액 또는 추출액의 피부 개선 효과를 검증하고자 하기와 같이 실시예 및 비교예를 설정하였다.In order to verify the skin improvement effect of the strain culture medium or extract of the present invention, Examples and Comparative Examples were set as follows.
본 발명자들이 분리한 Pseudozyma antarctica LAB-10 및 Pseudoalteromonas neustonica LAB-08 균주의 활성을 종래 남극 미생물(Pseudozyma antarctica ATCC34888, Pseudoalteromonas sp. PAMC28425)과 비교하였으며, 2종의 균주 배양액에 의한 시너지 활성을 검증하였다.The activities of Pseudozyma antarctica LAB-10 and Pseudoalteromonas neustonica LAB-08 strains isolated by the present inventors were compared with conventional Antarctic microorganisms ( Pseudozyma antarctica ATCC34888, Pseudoalteromonas sp. PAMC28425), and the synergistic activity by the two strain cultures was verified.
10% 농도의 배양액을 사용하였으며, 추출액은 1 mg/mL 농도로 하였다.A culture solution of 10% concentration was used, and the extract was 1 mg/mL concentration.
[함량(중량부)][Amount (parts by weight)]
구분division 실시예Example 비교예comparative example
1One 22 33 44 55 66 1One 22 33 44 55 66 77 88
Pseudozyma antarctica
LAB-10 배양액
Pseudozyma antarctica
LAB-10 culture medium
1010 -- -- -- 55 -- 2020 -- -- -- -- -- -- --
Pseudoalteromonas neustonicaLAB-08 배양액 Pseudoalteromonas neustonica LAB-08 culture medium 1010 -- -- -- 55 -- -- 2020 -- -- -- -- -- --
Pseudozyma antarcticaLAB-10 추출액 Pseudozyma antarctica LAB-10 Extract -- 1010 -- -- 55 -- -- -- 2020 -- -- -- -- --
Pseudoalteromonas neustonicaLAB-08 추출액 Pseudoalteromonas neustonica LAB-08 Extract -- 1010 -- -- 55 -- -- -- -- 2020 -- -- -- --
Pseudozyma antarctica ATCC34888 배양액(KCCM 11472) Pseudozyma antarctica ATCC34888 culture medium (KCCM 11472) -- -- 1010 -- -- 55 -- -- -- -- 2020 -- -- --
Pseudoalteromonas sp. PAMC28425 배양액(KCCM 43192) Pseudoalteromonas sp. PAMC28425 culture medium (KCCM 43192) -- -- 1010 -- -- 55 -- -- -- -- -- 2020 -- --
Pseudozyma antarctica ATCC34888 추출액(KCCM 11472) Pseudozyma antarctica ATCC34888 extract (KCCM 11472) -- -- -- 1010 -- 55 -- -- -- -- -- -- 2020 --
Pseudoalteromonas sp. PAMC28425 추출액(KCCM 43192) Pseudoalteromonas sp. PAMC28425 extract (KCCM 43192) -- -- -- 1010 -- 55 -- -- -- -- -- -- -- 2020
실험예 1 : 멜라닌 생성량 평가Experimental Example 1: Evaluation of melanin production
멜라민 함량 분석(melanin contents assay)를 통해 실시예 및 비교예의 시료에 의한 멜라닌 형성(melanogenesis) 저해능을 평가하였다.Melamine content analysis (melanin contents assay) was evaluated for melanogenesis inhibition by the samples of Examples and Comparative Examples.
B16F10 cell line을 10% FBS(fetal bovine serum)와 1X 페니실린/스트렙토마이신(P/S)이 함유된 DMEM 배지에 배양하고 세포를 카운팅하였다. The B16F10 cell line was cultured in DMEM medium containing 10% fetal bovine serum (FBS) and 1X penicillin/streptomycin (P/S), and the cells were counted.
24-well 플레이트에 2 x 104 cell/well이 되도록 희석하여 시딩(seeding)하고 5% CO2, 37℃ 배양기에서 24시간 배양하였다. Diluted to 2 x 10 4 cell/well in a 24-well plate, seeded (seeding), and cultured for 24 hours in a 5% CO 2 , 37°C incubator.
배양 후 10% FBS를 포함하는 배지에 α-msh(α-Melanocyte-stimulating hormone)를 100nM 처리하고 그 배지를 사용하여 시료를 농도별로 희석하여 처리하였다. After culturing, α-msh (α-Melanocyte-stimulating hormone) was treated with 100 nM in a medium containing 10% FBS, and samples were diluted by concentration using the medium.
양성 대조군(positive control)으로는 200ppm arbutin을 사용하였고, 시료와 함께 5% CO2, 37℃ 배양기에서 72시간 배양한 후 배지를 제거하고 DPBS로 cell을 워싱하였다. As a positive control, 200ppm arbutin was used, and the sample was cultured for 72 hours in a 5% CO 2 , 37°C incubator, and then the medium was removed and the cells were washed with DPBS.
1N NaOH(sodium hydroxide)를 120μL씩 넣고 5% CO2, 37℃ 배양기에서 30분동안 intracellular melanin을 용해시켰다.120 μL of 1N NaOH (sodium hydroxide) was added and intracellular melanin was dissolved in a 5% CO 2 , 37°C incubator for 30 minutes.
완전히 녹은 intracellular melanin을 100μL씩 96 well 플레이트에 옮기고, 흡광도 측정기기(Multikan Go, Thermo Fisher Scientific)을 이용하여 450nm 에서 흡광도를 측정하였다(도 1, 표 1). 100 μL of completely dissolved intracellular melanin was transferred to a 96 well plate, and absorbance was measured at 450 nm using an absorbance measuring device (Multikan Go, Thermo Fisher Scientific) (Fig. 1, Table 1).
α-msh 를 처리한 군을 control로 하여 결과값을 정리하였다.The group treated with α-msh was used as a control and the results were summarized.
구분division 멜라닌 생성량(흡광도)Amount of melanin produced (absorbance)
실시예 1Example 1 44.244.2
실시예 2Example 2 46.546.5
실시예 3Example 3 65.465.4
실시예 4Example 4 67.267.2
실시예 5Example 5 36.936.9
실시예 6Example 6 60.560.5
비교예 1Comparative Example 1 60.060.0
비교예 2Comparative Example 2 77.977.9
비교예 3Comparative Example 3 51.151.1
비교예 4Comparative Example 4 57.957.9
비교예 5Comparative Example 5 89.389.3
비교예 6Comparative Example 6 90.290.2
비교예 7Comparative Example 7 86.186.1
비교예 8Comparative Example 8 91.291.2
대조군 control group 100100
양성대조군positive control 47.947.9
표 2를 참조하면, 슈도지마 안타티카(Pseudozyma antarctica) 균주 및 슈도알테로모나스 뉴스토니카(Pseudoalteromonas neustonica) 균주 배양액 또는 추출액을 동시에 포함하는 실시예 1 내지 6은 각각의 단일 균주 배양액 또는 추출액 보다 효과적으로 멜라닌 생성을 억제하였다.Referring to Table 2, Pseudojima Antarctica ( Pseudozyma antarctica ) Strains and Pseudo Alteromonas New Stonica ( Pseudoalteromonas neustonica ) Examples 1 to 6 containing the strain culture or extract at the same time melanin more effectively than each single strain culture or extract production was inhibited.
특히, 각각의 균주 배양액 및 추출액을 동시에 포함하는 실시예 5 및 6의 경우 멜라닌 억제 활성이 더욱 증진되었다.In particular, in the case of Examples 5 and 6 containing the respective strain culture and extract at the same time, the melanin inhibitory activity was further enhanced.
또한, 단일 균주 간 비교하는 경우라도 본 발명자들이 분리한 Pseudozyma antarctica LAB-10 또는 Pseudoalteromonas neustonica LAB-08 균주 배양액이나 추출액(비교예 1 내지 4)은 종래의 남극 미생물 배양액 또는 추출액(비교예 5 내지 8) 대비 멜라닌 생성 억제능이 우수한 것으로 평가되었다.In addition, even when comparing single strains, the Pseudozyma antarctica LAB-10 or Pseudoalteromonas neustonica LAB-08 strain culture solution or extract (Comparative Examples 1 to 4) isolated by the present inventors is a conventional Antarctic microbial culture solution or extract (Comparative Examples 5 to 8 ) was evaluated as superior in melanin production inhibitory ability.
상기 결과는 Pseudozyma antarctica LAB-10 및 Pseudoalteromonas neustonica LAB-08 균주의 배양액이나 추출액이 종래 남극 미생물 배양액이나 추출액 대비 더 우수한 피부 개선 활성을 가지며, 동시에 적용될 때 상호 시너지 활성을 나타낼 수 있음을 시사한다.The above results suggest that the culture solutions or extracts of Pseudozyma antarctica LAB-10 and Pseudoalteromonas neustonica LAB-08 strains have better skin improvement activity than conventional Antarctic microorganism culture solutions or extracts, and can exhibit mutual synergistic activity when applied simultaneously.
실험예 2 : 피부 보습 활성 평가Experimental Example 2: Evaluation of skin moisturizing activity
실시예 및 비교예의 시료를 이용하여 피부 보습 효과를 평가하였다.The skin moisturizing effect was evaluated using the samples of Examples and Comparative Examples.
HaCaT cell line을 10% FBS(fetal bovine serum)와 1X 페니실린/스트렙토마이신(P/S)이 함유된DMEM 배지에 배양하고 세포를 카운팅한 뒤 6-well 플레이트에 5 x 105 cell/well이 되도록 희석하여 시딩하고 5% CO2, 37℃ 배양기에서 24시간 배양하였다.The HaCaT cell line was cultured in DMEM medium containing 10% FBS (fetal bovine serum) and 1X penicillin/streptomycin (P/S), and after counting the cells, the number was 5 x 10 5 cells/well in a 6-well plate. Diluted and seeded, 5% CO 2 , and cultured for 24 hours in an incubator at 37°C.
배양 후 1% FBS를 포함하는 세럼 프리 배지로 교체 후 기아상태(Starvation)로 만들어 24시간 동안 배양하였다.After culturing, it was replaced with a serum-free medium containing 1% FBS, and then cultured for 24 hours by starvation.
시료를 농도 별로 희석하여 처리하고, 양성 대조군(positive control)으로는 10M 레티놀(Retinoic Acid)을 사용하였다.Samples were diluted and treated according to concentration, and 10M retinol (Retinoic Acid) was used as a positive control.
10M 레티놀을 시료와 함께 5% CO2, 37℃ 배양기에서 24시간 배양한 후 배지를 제거하고 DPBS로 세척하였다. 10M retinol was incubated with the sample in a 5% CO 2 , 37°C incubator for 24 hours, and then the medium was removed and washed with DPBS.
각 시료의 세포에서 RNA Extraction Kit(TaKaRa Mini BEST Universal kit)를 이용해서 RNA를 분리한 뒤 Qubit Fluorometer로 RNA를 정량한 후, 각각 1μg의 RNA를 사용하여 증폭기에서 cDNA를 합성하였다(Step One Plus, Applied Biosystems). RNA was isolated from the cells of each sample using an RNA Extraction Kit (TaKaRa Mini BEST Universal kit), RNA was quantified with a Qubit Fluorometer, and cDNA was synthesized using an amplifier using 1 μg of RNA each (Step One Plus, Applied Biosystems).
Taqman primer AQP3, HAS3, GAPDH는 life technologies사에서 구입해서 사용하였다. Taqman master mix를 사용하여 Real time PCR 장비 Step One Plus Real-Time PCR (Applied Biosystem)를 이용하여 원하는 gene을 증폭하여 유전자 발현량의 변화를 확인하였다(표 3). Taqman primers AQP3, HAS3, and GAPDH were purchased from life technologies and used. Using the Taqman master mix, the desired gene was amplified using Real-time PCR equipment Step One Plus Real-Time PCR (Applied Biosystem) to confirm changes in gene expression (Table 3).
유전자의 발현량은 GAPDH 유전자에 대한 보정을 통해 최종적으로 분석하였다.The expression level of the gene was finally analyzed through correction for the GAPDH gene.
[Relative AQP3, HAS3/GAPDH mRNA][Relative AQP3, HAS3/GAPDH mRNA]
구분division AQP3 발현량 AQP3 expression level HAS3 발현량HAS3 expression level
실시예 1Example 1 2.862.86 3.923.92
실시예 2Example 2 2.592.59 4.324.32
실시예 3Example 3 1.631.63 1.961.96
실시예 4Example 4 1.721.72 1.871.87
실시예 5Example 5 3.213.21 6.736.73
실시예 6Example 6 2.022.02 2.822.82
비교예 1Comparative Example 1 0.880.88 1.261.26
비교예 2Comparative Example 2 1.421.42 1.481.48
비교예 3Comparative Example 3 0.670.67 1.461.46
비교예 4Comparative Example 4 1.541.54 3.443.44
비교예 5Comparative Example 5 0.960.96 1.051.05
비교예 6Comparative Example 6 0.740.74 0.970.97
비교예 7Comparative Example 7 0.530.53 0.740.74
비교예 8Comparative Example 8 0.670.67 1.461.46
대조군control group 1.011.01 1.021.02
양성대조군positive control 4.004.00 3.823.82
표 3을 참조하면, 슈도지마 안타티카(Pseudozyma antarctica) 균주 및 슈도알테로모나스 뉴스토니카(Pseudoalteromonas neustonica) 균주 배양액 또는 추출액을 동시에 포함하는 실시예 1 내지 6은 각각의 단일 균주 배양액 또는 추출액 대비 AQP3 및 HAS3 발현을 효과적으로 촉진하였다.Referring to Table 3, Pseudozyma antarctica ( Pseudozyma antarctica ) Strains and Pseudo Alteromonas New Stonica ( Pseudoalteromonas neustonica ) Examples 1 to 6 containing strain cultures or extracts at the same time are each single strain cultures or extracts compared to AQP3 and HAS3 expression was effectively promoted.
특히, 각각의 균주 배양액 및 추출액을 동시에 포함하는 실시예 5 및 6의 경우 AQP3 및 HAS3 발현을 더욱 효과적으로 촉진하였다.In particular, the expressions of AQP3 and HAS3 were more effectively promoted in the case of Examples 5 and 6 containing the respective strain culture and extract at the same time.
또한, 단일 균주 간 비교하는 경우라도 본 발명자들이 분리한 Pseudozyma antarctica LAB-10 또는 Pseudoalteromonas neustonica LAB-08 균주 배양액이나 추출액(비교예 1 내지 4)은 종래의 남극 미생물 배양액 또는 추출액(비교예 5 내지 8) 대비 피부 보습 활성이 우수한 것으로 평가되었다.In addition, even when comparing single strains, the Pseudozyma antarctica LAB-10 or Pseudoalteromonas neustonica LAB-08 strain culture solution or extract (Comparative Examples 1 to 4) isolated by the present inventors is a conventional Antarctic microbial culture solution or extract (Comparative Examples 5 to 8 ) was evaluated as excellent in skin moisturizing activity.
상기 결과는 Pseudozyma antarctica LAB-10 및 Pseudoalteromonas neustonica LAB-08 균주의 배양액이나 추출액이 종래 남극 미생물 배양액이나 추출액보다 더 효과적으로 아쿠아포린 단백질의 발현 및 히알루론산의 합성을 촉진시키며, 동시에 적용될 때 상호 시너지 활성을 나타낼 수 있음을 시사한다.The above results show that the culture broth or extract of Pseudozyma antarctica LAB-10 and Pseudoalteromonas neustonica LAB-08 strains promotes the expression of aquaporin protein and the synthesis of hyaluronic acid more effectively than the conventional Antarctic microorganism culture broth or extract, and synergistic activity when applied simultaneously. indicates that it can be expressed
실험예 3 : 피부톤 개선 활성 평가Experimental Example 3: Evaluation of skin tone improvement activity
실시예 5의 시료를 로션 타입으로 제형화하고, 피험자 20명을 대상으로 적용한 후 피부의 밝기 변화를 확인하였다.The sample of Example 5 was formulated into a lotion type, and after applying to 20 subjects, the change in skin brightness was confirmed.
시험자가 제공하는 기준 세안제를 이용하여 세안 후 페이퍼 타올로 가볍게 두드려 물기를 제거한 후 30 분간 항온, 항습 조건(20 내지 24℃, 40 내지 60% H)에서 안정을 취하게 한 후, MARK Vu(PSI PLUS, Korea)를 사용하여 안면부의 사진촬영을 실시하였다.After washing your face using the standard face wash provided by the tester, pat dry with a paper towel, and then let it rest in constant temperature and humidity conditions (20 to 24 ℃, 40 to 60% H) for 30 minutes, then MARK Vu (PSI PLUS, Korea) was used to take pictures of the facial part.
평가 시마다 동일한 부위에서 측정이 이루어질 수 있도록 측정 부위를 구획하였으며, 구획된 부위에 실시예 5 및 대조군을 각각 적용하였다.The measurement site was partitioned so that measurements could be made at the same site at each evaluation, and Example 5 and the control group were applied to the partitioned site, respectively.
Chromameter(CR-400, Konica-Minolta, Japan)의 측정은 각각 5회씩 시행한 후 측정치의 평균값을 측정값으로 기록하였다.Chromameter (CR-400, Konica-Minolta, Japan) was measured 5 times each, and then the average value of the measured values was recorded as the measured value.
시험 전, 시험 2주 후, 시험 4주 후에 Chromameter를 이용하여 피부 밝기(L-value)를 측정하고, 피부 밝기 개선율을 산출하였다(표 4, 도 4).Before the test, 2 weeks after the test, and 4 weeks after the test, skin brightness (L-value) was measured using a chromameter, and the skin brightness improvement rate was calculated (Table 4, FIG. 4).
구분division 실시예 5Example 5 대조군control group
측정값(AU)measured value (AU) 개선율improvement rate 측정값(AU)measured value (AU) 개선율improvement rate
시험전before exam 65.7165.71 -- 65.7665.76 --
2 주 후 After two weeks 66.4766.47 1.18% 1.18% 65.4065.40 -0.57% -0.57%
4주 후4 weeks later 68.1468.14 3.71% 3.71% 65.4265.42 -0.53% -0.53%
표 4를 참조하면, 실시예 5의 시료를 사용한 시험 부위는 시험 2주 후부터 시험 전에 비해 통계적으로 유의한 수준(p<0.05)으로 피부 밝기(L-value)가 증가하였다.Referring to Table 4, the test site using the sample of Example 5 increased skin brightness (L-value) at a statistically significant level (p <0.05) from 2 weeks after the test compared to before the test.
또한, 대조군을 사용한 대조 부위와의 비교에서도 통계적으로 유의한 수준(p<0.05)의 차이를 보여 실시예 5의 시료가 피부톤을 효과적으로 개선할 수 있음을 확인하였다.In addition, it was confirmed that the sample of Example 5 can effectively improve skin tone by showing a statistically significant difference (p<0.05) in comparison with the control area using the control group.
전술한 본 발명의 설명은 예시를 위한 것이며, 본 발명이 속하는 기술분야의 통상의 지식을 가진 자는 본 발명의 기술적 사상이나 필수적인 특징을 변경하지 않고서 다른 구체적인 형태로 쉽게 변형이 가능하다는 것을 이해할 수 있을 것이다. 그러므로 이상에서 기술한 실시예들은 모든 면에서 예시적인 것이며 한정적이 아닌 것으로 이해해야만 한다. 예컨대, 단일형으로 설명되어 있는 각 구성 요소는 분산되어 실시될 수도 있으며, 마찬가지로 분산된 것으로 설명되어 있는 구성 요소들도 결합된 형태로 실시될 수 있다.The above description of the present invention is for illustrative purposes, and those skilled in the art can understand that it can be easily modified into other specific forms without changing the technical spirit or essential features of the present invention. will be. Therefore, the embodiments described above should be understood as illustrative in all respects and not limiting. For example, each component described as a single type may be implemented in a distributed manner, and similarly, components described as distributed may also be implemented in a combined form.
본 발명의 범위는 후술하는 청구범위에 의하여 나타내어지며, 청구범위의 의미 및 범위 그리고 그 균등 개념으로부터 도출되는 모든 변경 또는 변형된 형태가 본 발명의 범위에 포함되는 것으로 해석되어야 한다.The scope of the present invention is indicated by the following claims, and all changes or modifications derived from the meaning and scope of the claims and equivalent concepts should be interpreted as being included in the scope of the present invention.
기탁기관명 : 한국생명공학연구원Name of Depositary Institution: Korea Research Institute of Bioscience and Biotechnology
수탁번호 : KCTC14550BPAccession number: KCTC14550BP
수탁일자 : 2021419Entrusted date: 2021419
기탁기관명 : 한국생명공학연구원Name of Depositary Institution: Korea Research Institute of Bioscience and Biotechnology
수탁번호 : KCTC14549BPAccession number: KCTC14549BP
수탁일자 : 2021419Entrusted date: 2021419
 
Figure WO-DOC-FIGURE-1
 
Figure WO-DOC-FIGURE-1
 
Figure WO-DOC-FIGURE-2
 
Figure WO-DOC-FIGURE-2

Claims (8)

  1. 슈도지마 안타티카(Pseudozyma antarctica) 균주, 이의 발효액, 파쇄액, 추출액 또는 배양액; 및 Pseudozyma antarctica strain, its fermentation broth, lysate, extract or culture medium; and
    슈도알테로모나스 뉴스토니카(Pseudoalteromonas neustonica) 균주, 이의 발효액, 파쇄액, 추출액 또는 배양액;을 유효성분으로 포함하는 화장료 조성물.Pseudo Alteromonas New Tonica ( Pseudoalteromonas neustonica ) strain, its fermentation broth, lysate, extract or culture; a cosmetic composition containing as an active ingredient.
  2. 제1항에 있어서,According to claim 1,
    상기 슈도지마 안타티카(Pseudozyma antarctica) 균주는 슈도지마 안타티카 LAB-10(수탁번호: KCTC 14550BP) 인, 화장료 조성물.The Pseudozyma antarctica strain is Pseudozyma antarctica LAB-10 (accession number: KCTC 14550BP ) phosphorus, cosmetic composition.
  3. 제1항에 있어서,According to claim 1,
    상기 슈도알테로모나스 뉴스토니카(Pseudoalteromonas neustonica) 균주는 슈도알테로모나스 뉴스토니카 LAB-08(수탁번호: KCTC 14549BP)인, 화장료 조성물.The pseudoalteromonas new tonica ( Pseudoalteromonas neustonica ) The strain is pseudoalteromonas new tonica LAB-08 (accession number: KCTC 14549BP), a cosmetic composition.
  4. 제1항에 있어서,According to claim 1,
    상기 배양액은 슈도지마 안타티카(Pseudozyma antarctica) 균주 또는 슈도알테로모나스 뉴스토니카(Pseudoalteromonas neustonica) 균주를 배양하여 수득된 배양액 자체, 또는 이로부터 균주를 제거하여 수득된 배양 상층액, 또는 배양 상층액의 농축물 또는 동결건조물인, 화장료 조성물.The culture solution is Pseudozyma antarctica strain or Pseudo Alteromonas New Stonica strain ( Pseudoalteromonas neustonica ) The culture medium itself obtained by culturing the strain, or the culture supernatant obtained by removing the strain therefrom, or the culture supernatant Concentrate or lyophilisate, a cosmetic composition.
  5. 제1항 내지 제4항 중 어느 한 항에 있어서,According to any one of claims 1 to 4,
    피부 보습 또는 피부장벽강화용인, 화장료 조성물.A cosmetic composition for skin moisturizing or skin barrier enhancement.
  6. 제1항 내지 제4항 중 어느 한 항에 있어서,According to any one of claims 1 to 4,
    피부 미백용 또는 피부톤 개선용인, 화장료 조성물.A cosmetic composition for skin whitening or skin tone improvement.
  7. 제1항 내지 제4항 중 어느 한 항에 있어서,According to any one of claims 1 to 4,
    유연화장수, 영양화장수, 수분크림, 영양크림, 마사지크림, 영양로션, 에센스, 앰플, 젤, 아이크림, 오일, 파운데이션, 클렌징크림, 클렌징폼, 클렌징워터, 마스크팩, 스프레이 및 파우더로 이루어진 군에서 선택된 하나의 제형으로 이루어진, 화장료 조성물.In the group consisting of softening lotion, nutrient lotion, moisturizing cream, nutrient cream, massage cream, nutrient lotion, essence, ampoule, gel, eye cream, oil, foundation, cleansing cream, cleansing foam, cleansing water, mask pack, spray and powder Consisting of one selected formulation, a cosmetic composition.
  8. 슈도지마 안타티카(Pseudozyma antarctica) 균주, 이의 발효액, 파쇄액, 추출액 또는 배양액; 및 Pseudozyma antarctica strain, its fermentation broth, lysate, extract or culture medium; and
    슈도알테로모나스 뉴스토니카(Pseudoalteromonas neustonica) 균주, 이의 발효액, 파쇄액, 추출액 또는 배양액;을 유효성분으로 포함하는 피부외용제 조성물.Pseudoalteromonas new tonica ( Pseudoalteromonas neustonica ) strain, its fermentation broth, lysate, extract or culture; a composition for external application for skin containing as an active ingredient.
PCT/KR2022/007832 2021-06-29 2022-06-02 Cosmetic composition comprising antarctic microorganism culture medium WO2023277367A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020210084867A KR102652692B1 (en) 2021-06-29 2021-06-29 A cosmetic compositon comprising antarctic microorganism
KR10-2021-0084867 2021-06-29

Publications (1)

Publication Number Publication Date
WO2023277367A1 true WO2023277367A1 (en) 2023-01-05

Family

ID=84692834

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2022/007832 WO2023277367A1 (en) 2021-06-29 2022-06-02 Cosmetic composition comprising antarctic microorganism culture medium

Country Status (2)

Country Link
KR (1) KR102652692B1 (en)
WO (1) WO2023277367A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009034090A (en) * 2007-07-09 2009-02-19 Toyobo Co Ltd Mannosyl erythritol lipid and method for producing the same
US20110195103A1 (en) * 2008-10-13 2011-08-11 Lipotec, S.A. Cosmetic or dermopharmaceutical composition containing pseudoalteromonas ferment extract
KR20170072341A (en) * 2014-10-31 2017-06-26 리포텍 에스.에이. Cosmetic and/or pharmaceutical composition containing a bacterial extracellular product from pseudoalteromonas antarctica, and use thereof
KR20180028131A (en) * 2016-09-08 2018-03-16 (주)아모레퍼시픽 Composition for skin whitening comprising mannosylerythritol lipid

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5344274B2 (en) 2007-11-22 2013-11-20 東洋紡株式会社 Novel mannosyl erythritol lipid and method for producing the same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009034090A (en) * 2007-07-09 2009-02-19 Toyobo Co Ltd Mannosyl erythritol lipid and method for producing the same
US20110195103A1 (en) * 2008-10-13 2011-08-11 Lipotec, S.A. Cosmetic or dermopharmaceutical composition containing pseudoalteromonas ferment extract
KR20170072341A (en) * 2014-10-31 2017-06-26 리포텍 에스.에이. Cosmetic and/or pharmaceutical composition containing a bacterial extracellular product from pseudoalteromonas antarctica, and use thereof
KR20180028131A (en) * 2016-09-08 2018-03-16 (주)아모레퍼시픽 Composition for skin whitening comprising mannosylerythritol lipid

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"Antarctic-G: Fulfill your dream skin with bright energy from Antarctica ", LABIO, NEWS LETTER, vol. 56, 28 June 2022 (2022-06-28), pages 1 - 33, XP093018310 *

Also Published As

Publication number Publication date
KR102652692B1 (en) 2024-04-01
KR20230003710A (en) 2023-01-06

Similar Documents

Publication Publication Date Title
WO2022145663A1 (en) Cosmetic composition comprising dead lactic acid bacteria lactobacillus plantarum mass or culture of lactic acid bacteria for preventing or alleviating skin aging
WO2022080839A1 (en) Antioxidant, anti-inflammatory and whitening composition comprising skin-derived lactic acid bacteria
CN113164797B (en) Novel cosmetic and dermatological use of Cistus polyrhachis extract
WO2017026855A1 (en) Composition for improving skin condition containing exopolysaccharide produced by ceriporia lacerata as active ingredient
WO2010079978A2 (en) Composition for improving inflammatory disease using abh antigens
WO2020218888A1 (en) Cosmetic composition for skin whitening containing novel lactobacillus rhamnosus lm1011 as active ingredient
KR20140066521A (en) Cosmetic composition with mucus from fish
KR101860352B1 (en) A cosmetic composition for treating demodex infestations comprising extract of artemisia apiaceae
KR101855207B1 (en) Cosmetic composition containing fermentative extract of terminalia ferdinandiana with increased amount of vitamin c fermented by aureobasidium pullulans
KR102373899B1 (en) Multifunctional cosmetic composition containing complex natural extracts effective for skin wrinkle improvement, whitening, cell regeneration, and wound healing as an active ingredient
WO2021256773A1 (en) Cosmetic composition comprising fermented chestnut husk extract or fraction thereof as active ingredient
JP2014240375A (en) Cosmetic
WO2023277367A1 (en) Cosmetic composition comprising antarctic microorganism culture medium
WO2023085612A1 (en) Method for producing fermented caviar oil using skin flora, and cosmetic composition comprising same
JP2003128515A (en) Cosmetic
WO2022039572A1 (en) Mycelial culture of novel porostereum sp. strain (kctc18837p) and cosmetic composition comprising same for improving skin condition
CN108403524A (en) A kind of efficient spot-eliminating composition and its application
WO2017138692A1 (en) Cosmetic composition for skin improvement, containing extract of nymphoides sp. plant
EP2218441B1 (en) Methods for the prevention and/or treatment of age spots
WO2021095966A1 (en) Skin-whitening cosmetics composition containing chlorella extract as active ingredient
JP6375087B2 (en) Cosmetics
WO2019190010A1 (en) Ethanol extraction composition of citri unshius pericarpium, magnolia officinalis, corydalis remota, and acacia catechu, having effects of skin wrinkle amelioration, moisturization, antioxidation, or inflammation reduction
WO2024049229A1 (en) Cosmetic composition for preventing or ameliorating skin diseases, comprising morus alba-derived compound as active ingredient
WO2024128370A1 (en) Cosmetic composition for whitening or wrinkle reduction, comprising fermentation product of pueraria lobata root extract
WO2024049226A1 (en) Cosmetic composition for preventing or ameliorating skin diseases comprising tribulus terrestris-derived compound as active ingredient

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22833423

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 22833423

Country of ref document: EP

Kind code of ref document: A1